André Carpentier

Prix et distinctions

• (2024) Étienne-LeBel Award. Université de Sherbrooke.
• (2022) Henry Friesen Lecturer Award. Canadian Society of Endocrinology and Metabolism.
• (2016) Prix des Fondateurs. Société Québécoise de Lipidologie, de Nutrition et de Métabolisme.
• (2016) Naranjan Dhalla Award for Innovative Investigators in Cardiovascular Sciences. International Academy of Cardiovascular Sciences.
• (2015) Fellow. Canadian Academy of Health Sciences.
• (2014) Physician Scientist Award. Canadian Lipoprotein Conference.
• (2013) Jean-de-Margerie Award. Université de Sherbrooke.
• (2013) Grand Prix d’excellence du Conseil d’administration. Centre Hospitalier Universitaire de Sherbrooke.
• (2013) Prix d’excellence Catégorie rayonnement du Conseil d'administration. Centre Hospitalier Universitaire de Sherbrooke.
• (2012) Young Scientist Award. Canadian Diabetes Association – Canadian Institutes of Health Research Institute of Nutrition Metabolism and Diabetes.
• (2012) Mérite Estrien. LaTribune/Radio-Canada.
• (2011) Diabetes Young Investigator Award. Canadian Society of Endocrinology and Metabolism.
• (2010) Pierre-et-Danielle-Bourgaux Award. Université de Sherbrooke.
• (2009) André Dupont Young Investigator Award. Club de Recherches Cliniques du Québec.
• (2009) Prix de la ministre, Profession MD volet « habitudes de vie ». Ministère de l’éducation, du loisir et du sport, Gouvernement du Québec.
• (2005) Scientist of the week. Canadians for Health Research.
• (2004) Prix d’excellence à la recherche. Centre Hospitalier Universitaire de Sherbrooke.
• (2004) Jonathan Ballon Award. Heart and Stroke Foundation Quebec.
• (2002) Young-Investigator Award. Société Québécoise de Lipidologie, de Nutrition et de Métabolisme.
• (2000) Travel Award. Banting and Best Diabetes Centre of the University of Toronto.
• (2000) Travel Award. Canadian Diabetes Association.
• (2000) 3rd Prize – category Clinical Investigation. Mount Sinai Hospital/University Health Network 1st Annual Department of Medicine Research Competition.
• (1999) Fellowship Award (declined). Fonds de Recherche du Québec - Santé.
• (1999) Fellowship Award (declined). Canadian Diabetes Association.
• (1999) Travel Award. Canadian Diabetes Association.
• (1999) Travel Award. American Diabetes Association.
• (1999) William S. Fenwick and the Edward Christie Stevens Fellowship in Medicine. University of Toronto.
• (1999) Hugh Sellers Fellowship Award (declined). Hugh Sellers Fellowship Award.
• (1997) Detweiler Fellowship Award (declined). Detweiler Fellowship Award.
• (1997) Fellowship Award (declined). Fonds de Recherche du Québec - Santé.
• (1997) Dean's Fund Award. Université de Sherbrooke.
• (1996) Poster presentation Award. Association des médecins endocrinologues du Québec.
• (1989) Summer Traineeship Award. Fonds de Recherche du Québec - Santé.
• (1988) Summer Traineeship Award. Fonds de Recherche du Québec - Santé.

Financement

• Subvention. The impact of adipose tissue insulin resistance and abdominal obesity on hepatic fatty acid metabolism in Type 1 diabetes. Diabetes Canada (Toronto, Canada). Research Diabetes Canada End Diabetes Award – OG-3-24-5856-AC. 447 144 $. (2025-2027).
• Subvention. Stimulating adipose tissue fatty acid disposal with low-dose, postprandial, intermittent niacin for the treatment of metabolic dysfunction-associated steatotic liver disease. Canadian Institutes of Health Research (Ottawa, Canada). 1 197 226 $. (2024-2029).
  Numéro de subvention : 202403PJT. Voir plus
• Subvention. Organ-specific contribution to cold-induced thermogenesis during the development of type 2 diabetes. Diabetes Canada (Toronto, Canada). 300 000 $. (2024-2026).
• Subvention. Documenting the Essential Conditions for Implementing Urban Trails in Canada: A Novel Triangulation Approach. Canadian Institutes of Health Research (Ottawa, Canada). 1 453 500 $. (2023-2028).
  Numéro de subvention : 202303PJT. Voir plus
• Subvention. ImagingT2D. Canada Foundation for Innovation (Ottawa, Canada). 6 575 104 $. (2023).
  Numéro de subvention : 43157. Voir plus
• Subvention. Exploring the use of 11C-acetate positron emission tomography to advance understanding of adaptive thermogenesis – a method-developping study. Fonds de Recherche du Québec - Santé (Montreal, Canada). CMDO Network - Initiative structurante intercentes. 40 000 $. (2023-2024).
• Subvention. Rencontre scientifique internationale conjointe SQLNM/CMDO : La chronobiologie dans les maladies cardiometaboliques. Canadian Institutes of Health Research (Ottawa, Canada). 10 000 $. (2023).
  Numéro de subvention : 202207PCS. Voir plus
• Subvention. Accelerating Clinical Trials (ACT) - Canada. Canadian Institutes of Health Research (Ottawa, Canada). 9 749 233 $. (2022-2025).
  Numéro de subvention : 202207CT1. Voir plus
• Subvention. Accelerating Clinical Trials (ACT) - Canada. Canadian Institutes of Health Research (Ottawa, Canada). 38 996 932 $. (2022-2025).
  Numéro de subvention : 202207CTR. Voir plus
• Subvention. The implication of human adipocyte hypertrophy in systemic lipid metabolism and insulin resistance. Canadian Institutes of Health Research (Ottawa, Canada). 76 500 $. (2022-2024).
  Numéro de subvention : 202111FBD. Voir plus
• Subvention. Mobilizing Knowledge and Implementing Equitable and Cost-Effective Health and Social Care Services for Persons Living with Diabetes in Canada. Canadian Institutes of Health Research (Ottawa, Canada). 3 750 000 $. (2022-2026).
  Numéro de subvention : 202112KMI. Voir plus
• Subvention. Improved adipose tissue storage of dietary fatty acids as a new mechanism for the rapid remission of hepatic and cardiac metabolic dysfunction after bariatric surgery. Canadian Institutes of Health Research (Ottawa, Canada). 956 250 $. (2022-2027).
  Numéro de subvention : 202109PJT. Voir plus
• Subvention. Precision medicine study of type 2 diabetes in the COLCOT-T2D trial. Canadian Institutes of Health Research (Ottawa, Canada). 1 800 000 $. (2022-2026).
  Numéro de subvention : 202107DT4. Voir plus
• Subvention. Training platform in diabetes, obesity and cardiometabolic health. Canadian Institutes of Health Research (Ottawa, Canada). 2 400 000 $. (2022-2027).
  Numéro de subvention : 202106RT8. Voir plus
• Subvention. Cardioprotective effect of a cyclic azapeptide ligand of CD36 against ischemia-reperfusion damage and dysfunction in mice. Canadian Institutes of Health Research (Ottawa, Canada). 726 750 $. (2021-2026).
  Numéro de subvention : 202104PJT. Voir plus
• Subvention. Precision medicine study of type 2 diabetes in the COLCOT-T2D trial. Canadian Institutes of Health Research (Ottawa, Canada). 10 000 $. (2021-2022).
  Numéro de subvention : 202012DL4. Voir plus
• Subvention. Targeting TMPRSS6 to treat hepcidin-deficiency disorders. Canadian Institutes of Health Research (Ottawa, Canada). 960 075 $. (2021-2026).
  Numéro de subvention : 202010PJT. Voir plus
• Subvention. Innovative National Strategies for Patient-Oriented Research Education / Strategies Nationales Innovantes pour l'Education en Recherche axee sur le Patient (INSPIRE). Canadian Institutes of Health Research (Ottawa, Canada). 5 250 000 $. (2021-2027).
  Numéro de subvention : 202012SNT. Voir plus
• Subvention. The Right Timing to prevent Type 2 Diabetes: Restoring 24-hour substrate rhythmicity to improve glycemic control by timing of lifestyle factors. Canadian Institutes of Health Research (Ottawa, Canada). 1 999 784 $. (2021-2025).
  Numéro de subvention : 202005TNC. Voir plus
• Subvention. Paradigm shift in the conduct of clinical trials. Ministère de l'Économie, de la Science et de l'Innovation - Québec (QC, Canada). FACS. 10 000 000 $. (2021-2025).
• Subvention. COLCOT-T2D : Colchicine for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes. Canadian Institutes of Health Research (Ottawa, Canada). 5 446 800 $. (2020-2025).
  Numéro de subvention : 202003PJT. Voir plus
• Subvention. Rôle des microARNs dans le métabolisme des acides gras alimentaires du diabète de type 2. Fonds de Recherche du Québec - Santé (Montreal, Canada). CMDO Network - Initiative structurante intercentes. 40 000 $. (2020-2021).
• Subvention. Les maladies cadiometaboliques a l'ere de la revolution numerique. Canadian Institutes of Health Research (Ottawa, Canada). 15 000 $. (2020).
  Numéro de subvention : 201909PCS. Voir plus
• Subvention. The Netherlands-Canada Type 2 Diabetes Research Consortium: The Right Timing to Prevent and Treat Type 2 Diabetes. Canadian Institutes of Health Research (Ottawa, Canada). 3 000 $. (2019-2020).
  Numéro de subvention : 201909NT1. Voir plus
• Subvention. Molecular Imaging of Diabetes. Canadian Institutes of Health Research (Ottawa, Canada). 1 400 000 $. (2018-2025).
  Numéro de subvention : 201804T1C. Voir plus
• Subvention. Quantifying Brown Adipose Tissue Thermogenesis in Obesity and Type 2 Diabetes. Canadian Institutes of Health Research (Ottawa, Canada). 1 077 722 $. (2018-2023).
  Numéro de subvention : 201803PJT. Voir plus
• Subvention. BEhaviors, Therapies, TEchnologies and hypoglycemic Risk in Type 1 diabetes: The BETTER study. Canadian Institutes of Health Research (Ottawa, Canada). 1 539 112 $. (2018-2022).
  Numéro de subvention : 201711JT1. Voir plus
• Subvention. Curbing Atherosclerosis through Precision Medicine. Ministère de l'Économie, de la Science et de l'Innovation - Québec (QC, Canada). FACS. 10 000 000 $. (2018-2022).
• Subvention. Réseau de recherche en santé cardiométabolique, diabète et obésité (CMDO). Fonds de Recherche du Québec - Santé (Montreal, Canada). 4 010 000 $. (2017-2024).
  Numéro de subvention : 35330. Voir plus
• Subvention. Améliorer la prédiction des issues cliniques du diabète de type 2 à l’aide de l’imagerie moléculaire. Ministère de l'Économie, de la Science et de l'Innovation - Québec (QC, Canada). PSRv2 Infrastructure Grant. 3 999 330 $. (2017-2018).
• Subvention. Congres scientifique international 2017 - COLosSUS/CMDO/SQLNM. Canadian Institutes of Health Research (Ottawa, Canada). 20 000 $. (2016-2017).
  Numéro de subvention : 201608PCS. Voir plus
• Subvention. Modulation and effects of IGFBP-2 on brown adipose tissue thermogenesis. Canadian Institutes of Health Research (Ottawa, Canada). 979 463 $. (2016-2021).
  Numéro de subvention : 201603PJT. Voir plus
• Subvention. SPOR Network in Diabetes and its Related Complications. Canadian Institutes of Health Research (Ottawa, Canada). 12 916 802 $. (2016-2022).
  Numéro de subvention : 201510SCA. Voir plus
• Subvention. Activation pharmacologique de la graisse brune chez l’humain. Merck Canada (QC, Canada). Merck - Faculty of Medicine Grant. 173 000 $. (2016-2017).
• Subvention. Gene Environment Team on Brown/beige Adipose Tissue (GET_BAT). Canadian Institutes of Health Research (Ottawa, Canada). 2 040 008 $. (2015-2020).
  Numéro de subvention : 201509ECD. Voir plus
• Subvention. Investigation of postprandial fatty acid metabolism in the natural history of type 2 diabetes mellitus (T2D). Canadian Institutes of Health Research (Ottawa, Canada). 1 174 020 $. (2015-2021).
  Numéro de subvention : 201503MOP. Voir plus
• Subvention. Postprandial energy metabolism of brown fat in humans. Canadian Institutes of Health Research (Ottawa, Canada). 90 000 $. (2015-2017).
  Numéro de subvention : 201411MFE. Voir plus
• Subvention. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas and sensor-augmented pump therapy in outpatient settings. National Institute of Diabetes and Digestive and Kidney Diseases (Md., États-Unis). 2 509 367 USD. (2015-2019).
• Subvention. Determinants of metabolic recovery following bariatric surgery in individuals with type 2 diabetes mellitus. Canadian Institutes of Health Research (Ottawa, Canada). 1 235 052 $. (2014-2019).
  Numéro de subvention : 201407TB2. Voir plus
• Subvention. Targeting Branch-Chain Amino Acid and Fatty Acid Catabolic Pathways for Treatment of Type 2 Diabetes. Canadian Institutes of Health Research (Ottawa, Canada). 6 000 $. (2014-2015).
  Numéro de subvention : 201502FSS. Voir plus
• Subvention. Etude du metabolisme postprandial des acides gras dans l'histoire naturelle du diabete de type 2 : contribution relative des lipides alimentaires vs. systemiques a l'apport des acides gras aux tissus non-adipeux et effet d'une augmentation de l'activite physique chez des sujets intolerants au glucose. Canadian Institutes of Health Research (Ottawa, Canada). 71 250 $. (2014-2015).
  Numéro de subvention : 201311MFE. Voir plus
• Subvention. Etude des mecanismes adipocytaires menant a l'amelioration de l'intolerance aux lipides apres la chirurgie bariatrique chez des patients diabetiques obeses. Canadian Institutes of Health Research (Ottawa, Canada). 105 000 $. (2014-2017).
  Numéro de subvention : 201310GSD. Voir plus
• Subvention. Postprandial metabolism after bariatric surgery in type 2 diabetes. Canadian Diabetes Association (ON, Canada). 278 779 $. (2014-2017).
• Subvention. Postprandial energy metabolism of brown fat in humans. Canadian Institutes of Health Research (Ottawa, Canada). 626 080 $. (2013-2018).
  Numéro de subvention : 201303MOP. Voir plus
• Subvention. La chirurgie de l'obesite est-elle un traitement miracle du diabete de type 2 ?. Canadian Institutes of Health Research (Ottawa, Canada). 3 000 $. (2013-2014).
  Numéro de subvention : 201305SCI. Voir plus
• Subvention. Brain melanocortin-4 receptor and sympathetically-mediated brown adipocyte thermogenesis. Canadian Institutes of Health Research (Ottawa, Canada). 580 729 $. (2012-2017).
  Numéro de subvention : 201109MOP. Voir plus
• Subvention. Les liens entre l'obesite et le diabete de type 2. Canadian Institutes of Health Research (Ottawa, Canada). 3 000 $. (2011-2012).
  Numéro de subvention : 201106SCI. Voir plus
• Subvention. CIHR/GSK Chair of Diabetes: abnormal lipid metabolism in the development of type 2 diabetes. Canadian Institutes of Health Research (Ottawa, Canada). 375 000 $. (2011-2016).
  Numéro de subvention : 201009XGS. Voir plus
• Subvention. Investigation of postprandial fatty acid metabolism in the natural history of type 2 diabetes mellitus (T2D). Canadian Institutes of Health Research (Ottawa, Canada). 871 191 $. (2011-2016).
  Numéro de subvention : 201009MOP. Voir plus
• Subvention. Investigations of cardiac metabolism using mass isotopomer analysis: A paradigm for biomarker and therapy discovery. Canadian Institutes of Health Research (Ottawa, Canada). 739 475 $. (2010-2015).
  Numéro de subvention : 201003MOP. Voir plus
• Subvention. Multimodal laboratory for in vivo investigation of disordered fatty acid metabolism in diabetes and cardiovascular disease. Canada Foundation for Innovation (Ottawa, Canada). 365 891 $. (2010).
  Numéro de subvention : 25396. Voir plus
• Subvention. Energy metabolism of brown fat in humans. Canadian Diabetes Association (ON, Canada). 329 055 $. (2010-2013).
• Subvention. Evanescent field biosensor for label-free and real-time in situ monitoring of multiple analytes ex vivo and in vivo. Québec Consortium for Drug Discovery (QC, Canada). 1 780 000 $. (2010-2013).
• Subvention. Azapeptides: A new class of CD36 ligands for the treatment of ischemic heart disease. Canadian Institutes of Health Research (Ottawa, Canada). 731 018 $. (2009-2014).
  Numéro de subvention : 200903MOP. Voir plus
• Subvention. Le métabolisme postprandial des acides gras dans la pathogenèse du diabète de type 2. Fonds de Recherche du Québec - Santé (Montreal, Canada). 126 275 $. (2009-2011).
  Numéro de subvention : 16196. Voir plus
• Subvention. Carbon-11 Acetoacetate: A New PET Tracer to Study Energy Metabolism in the Aging Human Brain. Canadian Institutes of Health Research (Ottawa, Canada). 50 000 $. (2009).
  Numéro de subvention : 200803IAP. Voir plus
• Subvention. Investigation of postprandial fatty acid metabolism in the natural history of type 2 diabetes mellitus (T2DM). Canadian Institutes of Health Research (Ottawa, Canada). 442 318 $. (2008-2011).
  Numéro de subvention : 200709MOP. Voir plus
• Subvention. Postprandial plasma free fatty acid metabolism and the innate and adaptive immune system in the metabolic syndrome. Heart and Stroke Foundation (Toronto, Canada). 51 000 $. (2007-2010).
• Subvention. Quantitative molecular PET imaging in mouse models of heart disease. Canadian Institutes of Health Research (Ottawa, Canada). 268 238 $. (2006-2009).
  Numéro de subvention : 200509MOP. Voir plus
• Subvention. Plate-forme integree d'imagerie moleculaire multi-modale en modele animal /integrated multimodality molecular imaging platform in animal models. Canadian Institutes of Health Research (Ottawa, Canada). 625 010 $. (2006-2011).
  Numéro de subvention : 200510PRG. Voir plus
• Subvention. Effect of exogenous fat delivery on in vivo adipose tissue function: implication for insulin resistance. Pfizer (Canada) (Kirkland, Canada). 199 500 $. (2006-2009).
• Subvention. Postprandial plasma free fatty acid metabolism and the innate and adaptive immune system in the metabolic syndrome. Canadian Diabetes Association (Toronto, Canada). 150 000 $. (2006-2007).
• Subvention. Integrated obesity care management system/ Programme integre de prise en charge de l'obesite. Canadian Institutes of Health Research (Ottawa, Canada). 100 000 $. (2005-2008).
  Numéro de subvention : 200505PHE. Voir plus
• Subvention. Investigation of the abnormalities of postprandial free fatty acid metabolism very early in the natural history of Type 2 Diabetes Mellitus. Canadian Institutes of Health Research (Ottawa, Canada). 410 911 $. (2005-2008).
  Numéro de subvention : 200409MOP. Voir plus
• Subvention. Intravascular lipolysis of triglyceride-rich lipoproteins on myocardial substrate selection in nutritional rat models of insulin resistance and type 2 diabetes. Heart And Stroke Foundation Of Quebec (QC, Canada). 47 174 $. (2004-2005).
• Subvention. Respective role of insulin and LH in the ovarian steroidogenic hyper-responsiveness of non-obese women with PCOS and normal insulin levels. Canadian Institutes of Health Research (Ottawa, Canada). 127 055 $. (2003-2006).
  Numéro de subvention : 200209MOP. Voir plus
• Subvention. CIUSSS de l'Estrie-Centre hospitalier universitaire de Sherbrooke (CHUS) - Centre de Recherche. Fonds de Recherche du Québec - Santé (Montreal, Canada). 35 067 120 $. (2003-2024).
  Numéro de subvention : 5248. Voir plus
• Subvention. Diabetogenic effects of prolonged evaluation of plasma free fatty acids in obese subjects with and without type 2 diabetes independent of chronic hyperglycemia. Canadian Diabetes Association (Toronto, Canada). 150 000 $. (2003-2004).
• Subvention. Métabolisme postprandial des lipides dans le diabète. Canada Foundation for Innovation (Ottawa, Canada). 120 921 $. (2002).
  Numéro de subvention : 7030. Voir plus
• Subvention. Investigation of the abnormalities of post-prandial free fatty acids metabolism very early in the natural history of Type 2 diabetes. Canadian Institutes of Health Research (Ottawa, Canada). 355 000 $. (2002-2005).
  Numéro de subvention : 200109MOP. Voir plus
• Subvention. Development of a new animal model using positron emission tomography to assess the effect of the modulation of postprandial intravascular lipolysis on in vivo myocardial energy substrate selection. Diabetes Québec (Montreal, Canada). 20 000 $. (2002).
• Subvention. Investigation of the abnormalities of post-prandial free fatty acid metabolism very early in the natural history of Type 2 diabetes mellitus. Canadian Institutes of Health Research (Ottawa, Canada). 118 714 $. (2001-2002).
  Numéro de subvention : 200009MOP. Voir plus
• Subvention. Investigation of the abnormalities of post-prandial free fatty acid metabolism very early in the natural history of type 2 diabetes mellitus. Canadian Institutes of Health Research (Ottawa, Canada). 294 716 $. (2001-2006).
  Numéro de subvention : 200009MSH. Voir plus
• Subvention. Programme interne de financement d’infrastructure des équipes de recherche (PIFIC). Centre de recherche en endocrinologie, métabolisme et signalisation (CREMS). Université de Sherbrooke (Sherbrooke, Canada). 362 076 $. (2001-2003).

Publications

Articles

• Naimi, F., Laflèche, C.R.D., Battista, M.-C., Carpentier, A.C., Baillargeon, J.-P. (2025). Antilipolytic Insulin Sensitivity Indices Measured during an Oral Glucose Challenge: Associations with Insulin-Glucose Clamp and Central Adiposity in Women without Diabetes. Endocrinology and Metabolism. DOI
• Lachance, A., Daoust, J., Pelletier, M., Caron, A., Carpentier, A.C., Biertho, L., Maranzano, J., Tchernof, A., Dadar, M., Michaud, A. (2025). Changes in hypothalamic subunits volume and their association with metabolic parameters and gastrointestinal appetite-regulating hormones following bariatric surgery. Imaging Neuroscience. DOI
• Mouisel, E., Bodon, A., Noll, C., Cassant-Sourdy, S., Marques, M.-A., Flores-Flores, R., Riant, E., Bergoglio, C., Vezin, P., Caspar-Bauguil, S., Fournes-Fraresso, C., Tavernier, G., Oumar, K.A.I., Gourdy, P., Blondin, D.P., Denechaud, P.-D., Carpentier, A.C., Langin, D. (2025). Cold-induced thermogenesis requires neutral-lipase-mediated intracellular lipolysis in brown adipocytes. Cell Metabolism. DOI
• Tang, A., Lepage, M., Rutter, G.A., Carpentier, A.C. (2025). Editorial: In vivo magnetic resonance imaging of metabolic disorders. Frontiers in Endocrinology. DOI
• Karavetian, M., Khoury, C.F.E., Rutters, F., Slebe, R., Lorenzetti, D., Blondin, D., Carpentier, A., Després, J.-P., Hoeks, J., Kalsbeek, A., de Mutsert, R., Pigeyre, M., Raina, P., Schrauwen, P., Serlie, M., Thieba, C., van der Velde, J., Campbell, D.J.T. (2025). Effect of timed exercise interventions on patient-reported outcome measures: A systematic review. Plos One. DOI
• Cypess, A.M., Cannon, B., Nedergaard, J., Kazak, L., Chang, D.C., Krakoff, J., Tseng, Y.-H., Schéele, C., Boucher, J., Petrovic, N., Blondin, D.P., Carpentier, A.C., Virtanen, K.A., Kooijman, S., Rensen, P.C.N., Cero, C., Kajimura, S. (2025). Emerging debates and resolutions in brown adipose tissue research. Cell Metabolism. DOI
• Townsend, L.K., Wang, D., Knuth, C.M., Fayyazi, R., Mohammad, A., Becker, L.J., Tsakiridis, E.E., Desjardins, E.M., Patel, Z., Valvano, C.M., Lu, J., Payne, A.E., Itua, O., Medak, K.D., Marko, D.M., Schertzer, J.D., Wright, D.C., Beaudette, S.M., Morrison, K.M., ... Steinberg, G.R. (2025). GDF15 links adipose tissue lipolysis with anxiety. Nature Metabolism. DOI
• Steinberg, G.R., Carpentier, A.C., Wang, D. (2025). MASH: the nexus of metabolism, inflammation, and fibrosis. Journal of Clinical Investigation. DOI
• Montastier, É., Ye, R.Z., Noll, C., Amrani, M., Frisch, F., Fortin, M., Bouffard, L., Phoenix, S., Sarrhini, O., Cunnane, S.C., Guérin, B., Turcotte, E.E., Carpentier, A.C. (2025). Nicotinic acid increases adipose tissue dietary fatty acid trapping and reduces postprandial hepatic and cardiac fatty acid uptake in prediabetes. European Journal of Pharmacology. DOI
• Dion, D., Noll, C., Fortin, M., Haroune, L., Saibi, S., Sarret, P., Carpentier, A.C. (2025). Plasma Endocannabinoids Are Independently Associated With the Metabolic Function of White Adipose Tissue. Journal of Clinical Endocrinology and Metabolism. DOI
• Dumont, L., Richard, G., Espagnet, R., Frisch, F., Fortin, M., Samson, A., Bouchard, J., Fontaine, R., Croteau, E., Phoenix, S., Dubreuil, S., Guérin, B., Turcotte, É.E., Carpentier, A.C., Blondin, D.P. (2025). Shivering, but not adipose tissue thermogenesis, increases as a function of mean skin temperature in cold-exposed men and women. Cell Metabolism. DOI
• Joshi, D., Pigeyre, M., Ali, M.U., de Mutsert, R., Rutters, F., Campbell, D., Despres, J.-P., Borhan, S., Rafiq, T., Slebe, R., Blondin, D., Carpentier, A., Hoeks, J., Kalsbeek, A., Schrauwen, P., Yi, C.-X., Raina, P. (2025). The association between clock gene polymorphisms and type 2 diabetes: A systematic review and meta-analysis. Diabetes and Metabolic Syndrome Clinical Research and Reviews. DOI
• Slebe, R., Splinter, J.J., Schoonmade, L.J., Blondin, D.P., Campbell, D.J.T., Carpentier, A.C., Després, J.-P., Hoeks, J., Kalsbeek, A., Raina, P., Schrauwen, P., Serlie, M.J., Stenvers, D.J., Yi, C.-X., de Mutsert, R., Beulens, J.W.J., Rutters, F. (2025). The effect of altered sleep timing on glycaemic outcomes: Systematic review of human intervention studies. Diabetes Obesity and Metabolism. DOI
• Ye, R.Z., Montastier, E., Frisch, F., Noll, C., Allard-Chamard, H., Gévry, N., Tchernof, A., Carpentier, A.C. (2024). Adipocyte hypertrophy associates with in vivo postprandial fatty acid metabolism and adipose single-cell transcriptional dynamics. Iscience. DOI
• Arsenault, B.J., Carpentier, A.C., Poirier, P., Després, J.-P. (2024). Adiposity, type 2 diabetes and atherosclerotic cardiovascular disease risk: Use and abuse of the body mass index. Atherosclerosis. DOI
• Blondin, D.P., Haman, F., Swibas, T.M., Hogan-Lamarre, S., Dumont, L., Guertin, J., Richard, G., Weissenburger, Q., Hildreth, K.L., Schauer, I., Panter, S., Wyland, L., Carpentier, A.C., Miao, Y., Shi, J., Juarez-Colunga, E., Kohrt, W.M., Melanson, E.L. (2024). Brown adipose tissue metabolism in women is dependent on ovarian status. American Journal of Physiology Endocrinology and Metabolism. DOI
• St-Pierre, V., Richard, G., Croteau, E., Fortier, M., Vandenberghe, C., Carpentier, A.C., Cuenoud, B., Cunnane, S.C. (2024). Cardiorenal ketone metabolism in healthy humans assessed by 11C-acetoacetate PET: effect of D-β-hydroxybutyrate, a meal, and age. Frontiers in Physiology. DOI
• Carpentier, A.C., Blondin, D.P. (2024). Is stimulation of browning of human adipose tissue a relevant therapeutic target?. Annales D Endocrinologie. DOI
• Shang, R., Lee, C.S., Wang, H., Dyer, R., Noll, C., Carpentier, A., Sultan, I., Alitalo, K., Boushel, R., Hussein, B., Rodrigues, B. (2024). Reduction in Insulin Uncovers a Novel Effect of VEGFB on Cardiac Substrate Utilization. Arteriosclerosis Thrombosis and Vascular Biology. DOI
• Elimam, H., Gauvin, J., Huynh, D.N., Ménard, L., Al-Hawat, M.-L., Harb, D., Lubell, W.D., Carpentier, A.C., Ong, H., Marleau, S. (2024). Targeting CD36 With EP 80317 Reduces Remote Inflammatory Response to Hind Limb Ischemia-Reperfusion in Mice. Journal of Biochemical and Molecular Toxicology. DOI
• Slebe, R., Wenker, E., Schoonmade, L.J., Bouman, E.J., Blondin, D.P., Campbell, D.J.T., Carpentier, A.C., Hoeks, J., Raina, P., Schrauwen, P., Serlie, M.J., Jan Stenvers, D., de Mutsert, R., Beulens, J.W.J., Rutters, F. (2024). The effect of preprandial versus postprandial physical activity on glycaemia: Meta-analysis of human intervention studies. Diabetes Research and Clinical Practice. DOI
• Dumont, L., Caron, A., Richard, G., Croteau, E., Fortin, M., Frisch, F., Phoenix, S., Dubreuil, S., Guérin, B., Turcotte, É.E., Carpentier, A.C., Blondin, D.P. (2024). The effects of the β1-adrenergic receptor antagonist bisoprolol administration on mirabegron-stimulated human brown adipose tissue thermogenesis. Acta Physiologica. DOI
• Carpentier, A.C. (2024). Tracers and imaging of fatty acid and energy metabolism of human adipose tissues. Physiology. DOI
• Carpentier, A.C., Blondin, D.P., Haman, F., Richard, D. (2023). Brown Adipose Tissue—A Translational Perspective. Endocrine Reviews. DOI
• Cuenoud, B., Croteau, E., St-Pierre, V., Richard, G., Fortier, M., Vandenberghe, C., Carpentier, A.C., Cunnane, S.C. (2023). Cardiorenal ketone metabolism: a positron emission tomography study in healthy humans. Frontiers in Physiology. DOI
• Carpentier, A.C., Blondin, D.P. (2023). Human brown adipose tissue is not enough to combat cardiometabolic diseases. Journal of Clinical Investigation. DOI
• Lemdjo, G., Kengne, A.P., Nouthe, B., Lucas, M., Carpentier, A., Ngueta, G. (2023). Humero-femoral index and diabetes risk in the US population– a case study. Journal of Diabetes and Metabolic Disorders. DOI
• Behzadi, P., Ravanelli, N., Gravel, H., Barry, H., Debray, A., Chaseling, G.K., Jacquemet, V., Neagoe, P.-E., Nigam, A., Carpentier, A.C., Sirois, M.G., Gagnon, D. (2022). Acute effect of passive heat exposure on markers of cardiometabolic function in adults with type 2 diabetes mellitus. Journal of Applied Physiology. DOI
• Grenier-Larouche, T., Kwee, L.C., Deleye, Y., Leon-Mimila, P., Walejko, J.M., McGarrah, R.W., Marceau, S., Trahan, S., Racine, C., Carpentier, A.C., Lusis, A.J., Ilkayeva, O., Vohl, M.-C., Huertas-Vazquez, A., Tchernof, A., Shah, S.H., Newgard, C.B., White, P.J. (2022). Altered branched-chain α-keto acid metabolism is a feature of NAFLD in individuals with severe obesity. Jci Insight. DOI
• Ye, R.Z., Noll, C., Richard, G., Lepage, M., Turcotte, É.E., Carpentier, A.C. (2022). DeepImageTranslator: A free, user-friendly graphical interface for image translation using deep-learning and its applications in 3D CT image analysis. Slas Technology. DOI
• Ye, R.Z., Richard, G., Gévry, N., Tchernof, A., Carpentier, A.C. (2022). Fat Cell Size: Measurement Methods, Pathophysiological Origins, and Relationships With Metabolic Dysregulations. Endocrine Reviews. DOI
• Richard, G., Blondin, D.P., Syed, S.A., Rossi, L., Fontes, M.E., Fortin, M., Phoenix, S., Frisch, F., Dubreuil, S., Guérin, B., Turcotte, É.E., Lepage, M., Surette, M.G., Schertzer, J.D., Steinberg, G.R., Morrison, K.M., Carpentier, A.C. (2022). High-fructose feeding suppresses cold-stimulated brown adipose tissue glucose uptake independently of changes in thermogenesis and the gut microbiome. Cell Reports Medicine. DOI
• Ahmed, B.A., Varah, N., Ong, F.J., Blondin, D.P., Gunn, E., Konyer, N.B., Singh, N.P., Noseworthy, M.D., Haman, F., Carpentier, A.C., Punthakee, Z., Steinberg, G.R., Morrison, K.M. (2022). Impaired Cold-Stimulated Supraclavicular Brown Adipose Tissue Activity in Young Boys With Obesity. Diabetes. DOI
• Brazeau, A.-S., Messier, V., Talbo, M.K., Gagnon, C., Taleb, N., Fortier, I., Wu, Z., Perkins, B.A., Carpentier, A.C., Bandini, A., Rabasa-Lhoret, R. (2022). Self-reported Severe and Nonsevere Hypoglycemia in Type 1 Diabetes: Population Surveillance Through the BETTER Patient Engagement Registry: Development and Baseline Characteristics. Canadian Journal of Diabetes. DOI
• Girard, R., Tremblay, S., Noll, C., St-Jean, S., Jones, C., Gélinas, Y., Maloum-Rami, F., Perreault, N., Laplante, M., Carpentier, A.C., Boudreau, F. (2022). The transcription factor hepatocyte nuclear factor 4A acts in the intestine to promote white adipose tissue energy storage. Nature Communications. DOI
• Ye, R.Z., Montastier, É., Noll, C., Frisch, F., Fortin, M., Bouffard, L., Phoenix, S., Guéerin, B., Turcotte, É.E., Carpentier, A.C. (2022). Total Postprandial Hepatic Nonesterified and Dietary Fatty Acid Uptake Is Increased and Insufficiently Curbed by Adipose Tissue Fatty Acid Trapping in Prediabetes With Overweight. Diabetes. DOI
• Kastner, M., Makarski, J., Seaton, M.B., Sedig, K., Bélanger, M., Carpentier, A.C., Gaudreau, A., Lourido, G., Murray, M., Dainty, K.N. (2022). Training the Next Generation of Diabetes Researchers: Evaluation of the Diabetes Action Canada Training and Mentoring Program. Canadian Journal of Diabetes. DOI
• Carpentier, A.C. (2021). 100thanniversary of the discovery of insulin perspective: Insulin and adipose tissue fatty acid metabolism. American Journal of Physiology Endocrinology and Metabolism. DOI
• Richard, G., Noll, C., Archambault, M., Lebel, R., Tremblay, L., Ait-Mohand, S., Guérin, B., Blondin, D.P., Carpentier, A.C., Lepage, M. (2021). Contribution of perfusion to the 11C-acetate signal in brown adipose tissue assessed by DCE-MRI and 68Ga-DOTA PET in a rat model. Magnetic Resonance in Medicine. DOI
• Lewis, G.F., Carpentier, A.C., Pereira, S., Hahn, M., Giacca, A. (2021). Direct and indirect control of hepatic glucose production by insulin. Cell Metabolism. DOI
• Sainsily, X., Coquerel, D., Giguère, H., Dumont, L., Tran, K., Noll, C., Ionescu, A.L., Côté, J., Longpré, J.-M., Carpentier, A., Marsault, É., Lesur, O., Sarret, P., Auger-Messier, M. (2021). Elabela Protects Spontaneously Hypertensive Rats From Hypertension and Cardiorenal Dysfunctions Exacerbated by Dietary High-Salt Intake. Frontiers in Pharmacology. DOI
• Faramia, J., Hao, Z., Mumphrey, M.B., Townsend, R.L., Miard, S., Carreau, A.-M., Nadeau, M., Frisch, F., Baraboi, E.-D., Grenier-Larouche, T., Noll, C., Li, M., Biertho, L., Marceau, S., Hould, F.-S., Lebel, S., Morrison, C.D., Münzberg, H., Richard, D., ... Picard, F. (2021). IGFBP-2 partly mediates the early metabolic improvements caused by bariatric surgery. Cell Reports Medicine. DOI
• Montastier, É., Zhou Ye, R., Noll, C., Bouffard, L., Fortin, M., Frisch, F., Phoenix, S., Guérin, B., Turcotte, É.E., Lewis, G.F., Carpentier, A.C. (2021). Increased postprandial nonesterified fatty acid efflux from adipose tissue in prediabetes is offset by enhanced dietary fatty acid adipose trapping. American Journal of Physiology Endocrinology and Metabolism. DOI
• Ahmed, B.A., Ong, F.J., Barra, N.G., Blondin, D.P., Gunn, E., Oreskovich, S.M., Szamosi, J.C., Syed, S.A., Hutchings, E.K., Konyer, N.B., Singh, N.P., Yabut, J.M., Desjardins, E.M., Anhê, F.F., Foley, K.P., Holloway, A.C., Noseworthy, M.D., Haman, F., Carpentier, A.C., ... Morrison, K.M. (2021). Lower brown adipose tissue activity is associated with non-alcoholic fatty liver disease but not changes in the gut microbiota. Cell Reports Medicine. DOI
• Després, J.-P., Carpentier, A.C., Tchernof, A., Neeland, I.J., Poirier, P. (2021). Management of Obesity in Cardiovascular Practice: JACC Focus Seminar. Journal of the American College of Cardiology. DOI
• Diallo, K., Dussault, S., Noll, C., Lopez, A.F., Rivard, A., Carpentier, A.C., Lim, G.E. (2020). 14-3-3ζ mediates an alternative, non-thermogenic mechanism in male mice to reduce heat loss and improve cold tolerance. Molecular Metabolism. DOI
• Poursharifi, P., Attané, C., Mugabo, Y., Al-Mass, A., Ghosh, A., Schmitt, C., Zhao, S., Guida, J., Lussier, R., Erb, H., Chenier, I., Peyot, M.-L., Joly, E., Noll, C., Carpentier, A.C., Murthy Madiraju, S.R., Prentki, M. (2020). Adipose ABHD6 regulates tolerance to cold and thermogenic programs. Jci Insight. DOI
• Turcotte, A.-F., Grenier-Larouche, T., Lacombe, J., Carreau, A.-M., Carpentier, A.C., Mac-Way, F., Tchernof, A., Richard, D., Biertho, L., Lebel, S., Marceau, S., Ferron, M., Gagnon, C. (2020). Association between changes in bioactive osteocalcin and glucose homeostasis after biliopancreatic diversion. Endocrine. DOI
• Carreau, A.-M., Noll, C., Blondin, D.P., Frisch, F., Nadeau, M., Pelletier, M., Phoenix, S., Cunnane, S.C., Guérin, B., Turcotte, E.E., Lebel, S., Biertho, L., Tchernof, A., Carpentier, A.C. (2020). Bariatric surgery rapidly decreases cardiac dietary fatty acid partitioning and hepatic insulin resistance through increased intra-abdominal adipose tissue storage and reduced spillover in type 2 diabetes. Diabetes. DOI
• Carpentier, A.C. (2020). Branched-chain Amino Acid Catabolism by Brown Adipose Tissue. Endocrinology United States. DOI
• Blondin, D.P., Nielsen, S., Kuipers, E.N., Severinsen, M.C., Jensen, V.H., Miard, S., Jespersen, N.Z., Kooijman, S., Boon, M.R., Fortin, M., Phoenix, S., Frisch, F., Guérin, B., Turcotte, É.E., Haman, F., Richard, D., Picard, F., Rensen, P.C.N., Scheele, C., Carpentier, A.C. (2020). Human Brown Adipocyte Thermogenesis Is Driven by β2-AR Stimulation. Cell Metabolism. DOI
• Baillargeon, J.-P., St-Cyr-Tribble, D., Xhignesse, M., Brown, C., Carpentier, A.C., Fortin, M., Grant, A., Simoneau-Roy, J., Langlois, M.-F. (2020). Impact of an educational intervention combining clinical obesity preceptorship with electronic networking tools on primary care professionals: a prospective study. BMC Medical Education. DOI
• Lacombe, J., Rifai, O.A., Loter, L., Moran, T., Turcotte, A.-F., Grenier-Larouche, T., Tchernof, A., Biertho, L., Carpentier, A.C., Prud'homme, D., Rabasa-Lhoret, R., Karsenty, G., Gagnon, C., Jiang, W., Ferron, M. (2020). Measurement of bioactive osteocalcin in humans using a novel immunoassay reveals association with glucose metabolism and β-cell function. American Journal of Physiology Endocrinology and Metabolism. DOI
• Cuenoud, B., Hartweg, M., Godin, J.-P., Croteau, E., Maltais, M., Castellano, C.-A., Carpentier, A.C., Cunnane, S.C. (2020). Metabolism of Exogenous D-Beta-Hydroxybutyrate, an Energy Substrate Avidly Consumed by the Heart and Kidney. Frontiers in Nutrition. DOI
• Noll, C., Montastier, É., Amrani, M., Kunach, M., Frisch, F., Fortin, M., Bouffard, L., Dubreuil, S., Phoenix, S., Cunnane, S.C., Guérin, B., Turcotte, E.E., Laville, M., Carpentier, A.C. (2020). Seven-day overfeeding enhances adipose tissue dietary fatty acid storage and decreases myocardial and skeletal muscle dietary fatty acid partitioning in healthy subjects. American Journal of Physiology Endocrinology and Metabolism. DOI
• Huynh, D.N., Elimam, H., Bessi, V.L., Ménard, L., Burelle, Y., Granata, R., Carpentier, A.C., Ong, H., Marleau, S. (2019). A linear fragment of unacylated ghrelin (UAG6−13) protects against myocardial ischemia/reperfusion injury in mice in a growth hormone secretagogue receptor-independent manner. Frontiers in Endocrinology. DOI
• Bourgeois, R., Piché, M.-E., Auclair, A., Grenier-Larouche, T., Mitchell, P.L., Poirier, P., Biertho, L., Marceau, S., Hould, F.-S., Biron, S., Lebel, S., Lescelleur, O., Julien, F., Martin, J., Tchernof, A., Mathieu, P., Carpentier, A.C., Arsenault, B.J. (2019). Acute and chronic effect of bariatric surgery on circulating autotaxin levels. Physiological Reports. DOI
• Richard, M.A., Blondin, D.P., Noll, C., Lebel, R., Lepage, M., Carpentier, A.C. (2019). Determination of a pharmacokinetic model for [11c]-acetate in brown adipose tissue. Ejnmmi Research. DOI
• Gerstein, H.C., Colhoun, H.M., Dagenais, G.R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J.S., Riddle, M.C., Rydén, L., Xavier, D., Atisso, C.M., Dyal, L., Hall, S., Rao-Melacini, P., Wong, G., Avezum, A., Basile, J., Chung, N., ... Zigrang, W. (2019). Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. DOI
• Gerstein, H.C., Colhoun, H.M., Dagenais, G.R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F.T., Riddle, M.C., Rydén, L., Xavier, D., Atisso, C.M., Dyal, L., Hall, S., Rao-Melacini, P., Wong, G., Avezum, A., Basile, J., Chung, N., ... Zigrang, W. (2019). Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet. DOI
• Turcotte, A.-F., Grenier-Larouche, T., Ung, R.-V., Simonyan, D., Carreau, A.-M., Carpentier, A.C., Mac-Way, F., Michou, L., Tchernof, A., Biertho, L., Lebel, S., Marceau, S., Gagnon, C. (2019). Effects of Biliopancreatic Diversion on Bone Turnover Markers and Association with Hormonal Factors in Patients with Severe Obesity. Obesity Surgery. DOI
• Taleb, N., Carpentier, A.C., Messier, V., Ladouceur, M., Haidar, A., Rabasa-Lhoret, R. (2019). Efficacy of artificial pancreas use in patients with type 2 diabetes using intensive insulin therapy: A randomized crossover pilot trial. Diabetes Care. DOI
• Girard, R., Darsigny, M., Jones, C., Maloum-Rami, F., Gélinas, Y., Carpentier, A.C., Laplante, M., Perreault, N., Boudreau, F. (2019). HNF4α is a novel regulator of intestinal glucose-dependent insulinotropic polypeptide. Scientific Reports. DOI
• Oreskovich, S.M., Ong, F.J., Ahmed, B.A., Konyer, N.B., Blondin, D.P., Gunn, E., Singh, N.P., Noseworthy, M.D., Haman, F., Carpentier, A.C., Punthakee, Z., Steinberg, G.R., Morrison, K.M. (2019). MRI Reveals Human Brown Adipose Tissue Is Rapidly Activated in Response to Cold. Journal of the Endocrine Society. DOI
• Petrus, P., Fernandez, T.L., Kwon, M.M., Huang, J.L., Lei, V., Safikhan, N.S., Karunakaran, S., O'Shannessy, D.J., Zheng, X., Catrina, S.-B., Albone, E., Laine, J., Virtanen, K., Clee, S.M., Kieffer, T.J., Noll, C., Carpentier, A.C., Johnson, J.D., Rydén, M., Conway, E.M. (2019). Specific loss of adipocyte CD248 improves metabolic health via reduced white adipose tissue hypoxia, fibrosis and inflammation. Ebiomedicine. DOI
• Carpentier, A.C. (2018). Abnormal Myocardial Dietary Fatty Acid Metabolism and Diabetic Cardiomyopathy. Canadian Journal of Cardiology. DOI
• Huynh, D.N., Bessi, V.L., Menard, L., Piquereau, J., Proul, C., Febbraio, M., Lubell, W.D., Carpentier, A.C., Burelle, Y., Ong, H., Marleau, S. (2018). Adiponectin has a pIVotal role in the cardioprotectIVe effect of CP-3(IV), a selectIVe CD36 azapeptide ligand, after transient coronary artery occlusion in mice. FASEB Journal. DOI
• Carpentier, A.C., Blondin, D.P., Virtanen, K.A., Richard, D., Haman, F., Turcotte, É.E. (2018). Brown adipose tissue energy metabolism in humans. Frontiers in Endocrinology. DOI
• Barrière, D.A., Noll, C., Roussy, G., Lizotte, F., Kessai, A., Kirby, K., Belleville, K., Beaudet, N., Longpré, J.-M., Carpentier, A.C., Geraldes, P., Sarret, P. (2018). Combination of high-fat/high-fructose diet and low-dose streptozotocin to model long-term type-2 diabetes complications. Scientific Reports. DOI
• Masse, M.-H., Richard, M.A., D'Aragon, F., St-Arnaud, C., Mayette, M., Adhikari, N.K.J., Fraser, W., Carpentier, A., Palanchuck, S., Gauthier, D., Lanthier, L., Touchette, M., Lamontagne, A., Chénard, J., Mehta, S., Sansoucy, Y., Croteau, E., Lepage, M., Lamontagne, F. (2018). Early Evidence of Sepsis-Associated Hyperperfusion-A Study of Cerebral Blood Flow Measured With MRI Arterial Spin Labeling in Critically Ill Septic Patients and Control Subjects. Critical Care Medicine. DOI
• Schrauwen-Hinderling, V.B., Carpentier, A.C. (2018). Molecular imaging of postprandial metabolism. Journal of Applied Physiology. DOI
• Bouchouirab, F.-Z., Fortin, M., Noll, C., Dubé, J., Carpentier, A.C. (2018). Plasma Palmitoyl-Carnitine (AC16:0) Is a Marker of Increased Postprandial Nonesterified Incomplete Fatty Acid Oxidation Rate in Adults With Type 2 Diabetes. Canadian Journal of Diabetes. DOI
• Ong, F.J., Ahmed, B.A., Oreskovich, S.M., Blondin, D.P., Haq, T., Konyer, N.B., Noseworthy, M.D., Haman, F., Carpentier, A.C., Morrison, K.M., Steinberg, G.R. (2018). Recent advances in the detection of brown adipose tissue in adult humans: A review. Clinical Science. DOI
• Boyer, M., Piché, M.-E., Auclair, A., Grenier-Larouche, T., Biertho, L., Marceau, S., Hould, F.-S., Biron, S., Lebel, S., Lescelleur, O., Julien, F., Martin, J., Tchernof, A., Carpentier, A.C., Poirier, P., Arsenault, B.J. (2017). Acute and chronic impact of bariatric surgery on plasma LDL cholesterol and PCSK9 levels in patients with severe obesity. Journal of Clinical Endocrinology and Metabolism. DOI
• Michaud, A., Grenier-Larouche, T., Caron-Dorval, D., Marceau, S., Biertho, L., Simard, S., Richard, D., Tchernof, A., Carpentier, A.C. (2017). Biliopancreatic diversion with duodenal switch leads to better postprandial glucose level and beta cell function than sleeve gastrectomy in individuals with type 2 diabetes very early after surgery. Metabolism Clinical and Experimental. DOI
• Noll, C., Carpentier, A.C. (2017). Dietary fatty acid metabolism in prediabetes. Current Opinion in Lipidology. DOI
• Blondin, D.P., Tingelstad, H.C., Noll, C., Frisch, F., Phoenix, S., Guérin, B., Turcotte, É.E., Richard, D., Haman, F., Carpentier, A.C. (2017). Dietary fatty acid metabolism of brown adipose tissue in cold-acclimated men. Nature Communications. DOI
• Grenier-Larouche, T., Carreau, A.-M., Carpentier, A.C. (2017). Early Metabolic Improvement After Bariatric Surgery: The First Steps Toward Remission of Type 2 Diabetes. Canadian Journal of Diabetes. DOI
• Grenier-Larouche, T., Carreau, A.-M., Geloën, A., Frisch, F., Biertho, L., Marceau, S., Lebel, S., Hould, F.-S., Richard, D., Tchernof, A., Carpentier, A.C. (2017). Fatty Acid Metabolic Remodeling During Type 2 Diabetes Remission After Bariatric Surgery. Diabetes. DOI
• Blondin, D.P., Daoud, A., Taylor, T., Tingelstad, H.C., Bézaire, V., Richard, D., Carpentier, A.C., Taylor, A.W., Harper, M.-E., Aguer, C., Haman, F. (2017). Four-week cold acclimation in adult humans shifts uncoupling thermogenesis from skeletal muscles to brown adipose tissue. Journal of Physiology. DOI
• St-Jean, M., Boudreau, F., Carpentier, A.C., Hivert, M.-F. (2017). HNF1α defect influences post-prandial lipid regulation. Plos One. DOI
• Tricot, B., Descoteaux, M., Dumont, M., Chagnon, F., Tremblay, L., Carpentier, A., Lesur, O., Lepage, M., Lalande, A. (2017). Improving the evaluation of cardiac function in rats at 7T with denoising filters: A comparison study. BMC Medical Imaging. DOI
• Blondin, D.P., Frisch, F., Phoenix, S., Guérin, B., Turcotte, É.E., Haman, F., Richard, D., Carpentier, A.C. (2017). Inhibition of Intracellular Triglyceride Lipolysis Suppresses Cold-Induced Brown Adipose Tissue Metabolism and Increases Shivering in Humans. Cell Metabolism. DOI
• Chénard, T., Guénard, F., Vohl, M.-C., Carpentier, A., Tchernof, A., Najmanovich, R.J. (2017). Remodeling adipose tissue through in silico modulation of fat storage for the prevention of type 2 diabetes. BMC Systems Biology. DOI
• Gerstein, H.C., Bosch, J., Dagenais, G.R., Díaz, R., Jung, H., Maggioni, A.P., Pogue, J., Probstfield, J., Ramachandran, A., Riddle, M.C., Rydén, L.E., Yusuf, S., Richardson, L., Diaz, R., Johnston, P., Vige, R., Birkeland, K., Budaj, A., Cardona, E., ... Urbaneja, H. (2016). Cardiovascular and other outcomes postintervention with insulin glargine and omega-3 fatty acids (ORIGINALE). Diabetes Care. DOI
• Lacraz, G., Rakotoarivelo, V., Labbé, S.M., Vernier, M., Noll, C., Mayhue, M., Stankova, J., Schwertani, A., Grenier, G., Carpentier, A., Richard, D., Ferbeyre, G., Fradette, J., Rola-Pleszczynski, M., Menendez, A., Langlois, M.-F., Ilangumaran, S., Ramanathan, S. (2016). Deficiency of interleukin-15 confers resistance to obesity by diminishing inflammation and enhancing the thermogenic function of adipose tissues. Plos One. DOI
• Ruiz, M., Coderre, L., Lachance, D., Houde, V., Martel, C., Legault, J.T., Gillis, M.-A., Bouchard, B., Daneault, C., Carpentier, A.C., Gaestel, M., Allen, B.G., Des Rosiers, C. (2016). MK2 deletion in mice prevents diabetes-induced perturbations in lipid metabolism and cardiac dysfunction. Diabetes. DOI
• Noll, C., Labbé, S.M., Pinard, S., Shum, M., Bilodeau, L., Chouinard, L., Phoenix, S., Lecomte, R., Carpentier, A.C., Gallo-Payet, N. (2016). Postprandial fatty acid uptake and adipocyte remodeling in angiotensin type 2 receptor-deficient mice fed a high-fat/high-fructose diet. Adipocyte. DOI
• Blondin, D.P., Carpentier, A.C. (2016). The role of BAT in cardiometabolic disorders and aging. Best Practice and Research Clinical Endocrinology and Metabolism. DOI
• Blondin, D.P., Labbé, S.M., Turcotte, E.E., Haman, F., Richard, D., Carpentier, A.C. (2015). A critical appraisal of brown adipose tissue metabolism in humans. Clinical Lipidology. DOI
• Carpentier, A.C. (2015). Acute adaptation of energy expenditure predicts diet-induced weight loss: Revisiting the thrifty phenotype. Diabetes. DOI
• Blondin, D.P., Labbé, S.M., Phoenix, S., Guérin, B., Turcotte, E.E., Richard, D., Carpentier, A.C., Haman, F. (2015). Contributions of white and brown adipose tissues and skeletal muscles to acute cold-induced metabolic responses in healthy men. Journal of Physiology. DOI
• Kunach, M., Noll, C., Phoenix, S., Guérin, B., Baillargeon, J.-P., Turcotte, E.E., Carpentier, A.C. (2015). Effect of sex and impaired glucose tolerance on organ-specific dietary fatty acid metabolism in humans. Diabetes. DOI
• Green, J.B., Bethel, M.A., Armstrong, P.W., Buse, J.B., Engel, S.S., Garg, J., Josse, R., Kaufman, K.D., Koglin, J., Korn, S., Lachin, J.M., McGuire, D.K., Pencina, M.J., Standl, E., Stein, P.P., Suryawanshi, S., de Werf, F.V., Peterson, E.D., Holman, R.R., ... Zimmerman, R. (2015). Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. New England Journal of Medicine. DOI
• Bellanger, S., Benrezzak, O., Battista, M.C., Naimi, F., Labbè, S.M., Frisch, F., Normand-Lauzière, F., Gallo-Payet, N., Carpentier, A.C., Baillargeon, J.-P. (2015). Experimental dog model for assessment of fasting and postprandial fatty acid metabolism: Pitfalls and feasibility. Laboratory Animals. DOI
• Carpentier, A.C. (2015). Hypertriglyceridemia associated with abdominal obesity getting contributing factors into perspective. Arteriosclerosis Thrombosis and Vascular Biology. DOI
• Pereira, S., Breen, D.M., Naassan, A.E., Wang, P.Y.T., Uchino, H., Fantus, I.G., Carpentier, A.C., Gutierrez-Juarez, R., Brindley, D.N., Lam, T.K.T., Giacca, A. (2015). In vivo effects of polyunsaturated, monounsaturated, and saturated fatty acids on hepatic and peripheral insulin sensitivity. Metabolism Clinical and Experimental. DOI
• Labbé, S.M., Caron, A., Bakan, I., Laplante, M., Carpentier, A.C., Lecomte, R., Richard, D. (2015). In vivo measurement of energy substrate contribution to cold-induced brown adipose tissue thermogenesis. FASEB Journal. DOI
• Grenier-Larouche, T., Galinier, A., Casteilla, L., Carpentier, A.C., Tchernof, A. (2015). Omental adipocyte hypertrophy relates to coenzyme Q10 redox state and lipid peroxidation in obese women. Journal of Lipid Research. DOI
• Blondin, D.P., Labbé, S.M., Noll, C., Kunach, M., Phoenix, S., Guérin, B., Turcotte, E.E., Haman, F., Richard, D., Carpentier, A.C. (2015). Selective impairment of glucose but not fatty acid or oxidative metabolism in brown adipose tissue of subjects with type 2 diabetes. Diabetes. DOI
• Noll, C., Kunach, M., Frisch, F., Bouffard, L., Dubreuil, S., Jean-Denis, F., Phoenix, S., Cunnane, S.C., Guérin, B., Turcotte, E.E., Carpentier, A.C. (2015). Seven-day caloric and saturated fat restriction increases myocardial dietary fatty acid partitioning in impaired glucose-tolerant subjects. Diabetes. DOI
• Thibault, V., Morisset, A.-S., Brown, C., Carpentier, A.C., Baillargeon, J.-P., Langlois, M.-F., Gagnon, C. (2015). The increase in serum 25-hydroxyvitamin D following weight loss does not contribute to the improvement in insulin sensitivity, insulin secretion and β-cell function. British Journal of Nutrition. DOI
• White, W.B., Cannon, C.P., Heller, S.R., Nissen, S.E., Bergenstal, R.M., Bakris, G.L., Perez, A.T., Fleck, P.R., Mehta, C.R., Kupfer, S., Wilson, C., Cushman, W.C., Zannad, F., Aiub, J., Albisu, J., Alvarez, C., Astesiano, A., Barcudi, R., Bendersky, M., ... Knapp, B. (2014). Alogliptin after acute coronary syndrome in patients with type 2 diabetes. Austrian Journal of Clinical Endocrinology and Metabolism.
• Leblanc, S., Battista, M.-C., Noll, C., Hallberg, A., Gallo-Payet, N., Carpentier, A.C., Vine, D.F., Baillargeon, J.-P. (2014). Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome. Endocrinology United States. DOI
• Anderson, T.J., Grégoire, J., Hegele, R.A., Couture, P., Mancini, G.B.J., McPherson, R., Francis, G.A., Poirier, P., Lau, D.C., Grover, S., Genest, J., Carpentier, A.C., Dufour, R., Gupta, M., Ward, R., Leiter, L.A., Lonn, E., Ng, D.S., Pearson, G.J., ... Ur, E. (2014). Are the ACC/AHA Guidelines on the Treatment of Blood Cholesterol a Game Changer? A Perspective From the Canadian Cardiovascular Society Dyslipidemia Panel. Canadian Journal of Cardiology. DOI
• Plourde, C.-E., Grenier-Larouche, T., Caron-Dorval, D., Biron, S., Marceau, S., Lebel, S., Biertho, L., Tchernof, A., Richard, D., Carpentier, A.C. (2014). Biliopancreatic diversion with duodenal switch improves insulin sensitivity and secretion through caloric restriction. Obesity. DOI
• Genest, J., Hegele, R.A., Bergeron, J., Brophy, J., Carpentier, A., Couture, P., Davignon, J., Dufour, R., Frohlich, J., Gaudet, D., Gupta, M., Krisnamoorthy, P., Mancini, J., McCrindle, B., Raggi, P., Ruel, I., St-Pierre, J. (2014). Canadian Cardiovascular Society Position Statement onFamilial Hypercholesterolemia. Canadian Journal of Cardiology. DOI
• Lacerte, G., Langlois, M.-F., Doyon, M., Brown, C., Carpentier, A.C., Hivert, M.-F. (2014). Differential impact of changes in adiposity distribution on insulin resistance and adiponectin variations over 4 years in normal weight young adults. Hormone and Metabolic Research. DOI
• Gagnon, C., Daly, R.M., Carpentier, A., Lu, Z.X., Shore-Lorenti, C., Sikaris, K., Jean, S., Ebeling, P.R. (2014). Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and β-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: A pilot randomized, placebo-controlled trial. Plos One. DOI
• Labbé, S.M., Noll, C., Grenier-Larouche, T., Kunach, M., Bouffard, L., Phoenix, S., Guérin, B., Baillargeon, J.-P., Langlois, M.-F., Turcotte, E.E., Carpentier, A.C. (2014). Improved cardiac function and dietary fatty acid metabolism after modest weight loss in subjects with impaired glucose tolerance. American Journal of Physiology Endocrinology and Metabolism. DOI
• Blondin, D.P., Labbé, S.M., Tingelstad, H.C., Noll, C., Kunach, M., Phoenix, S., Guérin, B., Turcotte, É.E., Carpentier, A.C., Richard, D., Haman, F. (2014). Increased brown adipose tissue oxidative capacity in cold-acclimated humans. Journal of Clinical Endocrinology and Metabolism. DOI
• Veilleux, A., Grenier, E., Marceau, P., Carpentier, A.C., Richard, D., Levy, E. (2014). Intestinal lipid handling: Evidence and implication of insulin signaling abnormalities in human obese subjects. Arteriosclerosis Thrombosis and Vascular Biology. DOI
• Biet, M., Morin, N., Benrezzak, O., Naimi, F., Bellanger, S., Baillargeon, J.P., Chouinard, L., Gallo-Payet, N., Carpentier, A.C., Dumaine, R. (2014). Lasting alterations of the sodium current by short-term hyperlipidemia as a mechanism for initiation of cardiac remodeling. American Journal of Physiology Heart and Circulatory Physiology. DOI
• Dutia, R., Brakoniecki, K., Bunker, P., Paultre, F., Homel, P., Carpentier, A.C., McGinty, J., Laferrère, B. (2014). Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission. Diabetes. DOI
• Dutia, R., Brakoniecki, K., Bunker, P., Paultre, F., Homel, P., Carpentier, A.C., McGinty, J., Laferrère, B. (2014). Response to comment on Dutia et al. Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission. Diabetes 2014;63:1214-1223. Diabetes. DOI
• Croteau, E., Tremblay, S., Gascon, S., Dumulon-Perreault, V., Labbé, S.M., Rousseau, J.A., Cunnane, S.C., Carpentier, A.C., Bénard, F., Lecomte, R. (2014). [11C]-Acetoacetate PET imaging: A potential early marker for cardiac heart failure. Nuclear Medicine and Biology. DOI
• Anderson, T.J., Grégoire, J., Hegele, R.A., Couture, P., Mancini, G.B.J., McPherson, R., Francis, G.A., Poirier, P., Lau, D.C., Grover, S., Genest, J., Carpentier, A.C., Dufour, R., Gupta, M., Ward, R., Leiter, L.A., Lonn, E., Ng, D.S., Pearson, G.J., ... Ur, E. (2013). 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Canadian Journal of Cardiology. DOI
• Forget, G., Doyon, M., Lacerte, G., Labonté, M., Brown, C., Carpentier, A.C., Langlois, M.-F., Hivert, M.-F. (2013). Adoption of American Heart Association 2020 Ideal Healthy Diet Recommendations Prevents Weight Gain in Young Adults. Journal of the Academy of Nutrition and Dietetics. DOI
• White, W.B., Cannon, C.P., Heller, S.R., Nissen, S.E., Bergenstal, R.M., Bakris, G.L., Perez, A.T., Fleck, P.R., Mehta, C.R., Kupfer, S., Wilson, C., Cushman, W.C., Zannad, F., Aiub, J., Albisu, J., Alvarez, C., Astesiano, A., Barcudi, R., Bendersky, M., ... Barchha, N. (2013). Alogliptin after acute coronary syndrome in patients with type 2 diabetes. New England Journal of Medicine. DOI
• Shum, M., Pinard, S., Guimond, M.-O., Labbé, S.M., Roberge, C., Baillargeon, J.-P., Langlois, M.-F., Alterman, M., Wallinder, C., Hallberg, A., Carpentier, A.C., Gallo-Payet, N. (2013). Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats. American Journal of Physiology Endocrinology and Metabolism. DOI
• Poirier, P., Dufour, R., Carpentier, A.C., Larose, É. (2013). Dépistage de la coronaropathie. Canadian Journal of Diabetes. DOI
• Bernatchez, G., Giroux, V., Lassalle, T., Carpentier, A.C., Rivard, N., Carrier, J.C. (2013). ERRα metabolic nuclear receptor controls growth of colon cancer cells. Carcinogenesis. DOI
• Borel, A.-L., Boulet, G., Nazare, J.-A., Smith, J., Alméras, N., Tremblay, A., Bergeron, J., Poirier, P., Carpentier, A.C., Després, J.-P. (2013). Improved plasma FFA/insulin homeostasis is independently associated with improved glucose tolerance after a 1-year lifestyle intervention in viscerally obese men. Diabetes Care. DOI
• Allard, C., Doyon, M., Brown, C., Carpentier, A.C., Langlois, M.-F., Hivert, M.-F. (2013). Lower leptin levels are associated with higher risk of weight gain over 2 years in healthy young adults. Applied Physiology Nutrition and Metabolism. DOI
• Poirier, P., Dufour, R., Carpentier, A., Larose, É. (2013). Screening for the Presence of Coronary Artery Disease. Canadian Journal of Diabetes. DOI
• Carpentier, A.C. (2013). The 2012 CDA-CIHR INMD Young Investigator Award Lecture: Dysfunction of Adipose Tissues and the Mechanisms of Ectopic Fat Deposition in Type 2 Diabetes. Canadian Journal of Diabetes. DOI
• Chechi, K., Carpentier, A.C., Richard, D. (2013). Understanding the brown adipocyte as a contributor to energy homeostasis. Trends in Endocrinology and Metabolism. DOI
• VandenBerg, P., Carpentier, A. (2012). 2012 canadian diabetes associationecanadian institutes of health research institute of nutrition, metabolism and diabetes young scientist award recipient Dr. André Carpentier. Canadian Journal of Diabetes. DOI
• Gallo-Payet, N., Shum, M., Baillargeon, J.-P., Langlois, M.-F., Wallinder, C., Alterman, M., Hallberg, A., Carpentier, A.C. (2012). AT2 receptor agonists: Exploiting the beneficial Arm of Ang II signaling. Current Hypertension Reviews. DOI
• Trottier, A., Battista, M.-C., Geller, D.H., Moreau, B., Carpentier, A.C., Simoneau-Roy, J., Baillargeon, J.-P. (2012). Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome. Fertility and Sterility. DOI
• Gerstein, H.C., Bosch, J., Dagenais, G.R., Díaz, R., Jung, H., Maggioni, A.P., Pogue, J., Probstfield, J., Ramachandran, A., Riddle, M.C., Rydén, L.E., Yusuf, S., Richardson, L., Diaz, R., Johnston, P., Vige, R., Birkeland, K., Budaj, A., Cardona, E., ... Urbaneja, H. (2012). Basal insulin and cardiovascular and other outcomes in dysglycemia. New England Journal of Medicine. DOI
• Ouellet, V., Labbé, S.M., Blondin, D.P., Phoenix, S., Guérin, B., Haman, F., Turcotte, E.E., Richard, D., Carpentier, A.C. (2012). Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. Journal of Clinical Investigation. DOI
• Bessi, V.L., Labbé, S.M., Huynh, D.N., Ménard, L., Jossart, C., Febbraio, M., Guérin, B., Bentourkia, M., Lecomte, R., Carpentier, A.C., Ong, H., Marleau, S. (2012). EP 80317, a selective CD36 ligand, shows cardioprotective effects against post-ischaemic myocardial damage in mice. Cardiovascular Research. DOI
• Carpentier, A.C., Frisch, F., Labbe, S.M., Gagnon, R., De Wal, J., Greentree, S., Petry, H., Twisk, J., Brisson, D., Gaudet, D. (2012). Effect of alipogene tiparvovec (aav1-lpls447x) on postprandial chylomicron metabolism in Lipoprotein lipase-deficient patients. Journal of Clinical Endocrinology and Metabolism. DOI
• Sénéchal, M., Arguin, H., Bouchard, D.R., Carpentier, A.C., Ardilouze, J.-L., Dionne, I.J., Brochu, M. (2012). Effects of rapid or slow weight loss on body composition and metabolic risk factors in obese postmenopausal women. A pilot study. Appetite. DOI
• Labbé, S.M., Grenier-Larouche, T., Noll, C., Phoenix, S., Guérin, B., Turcotte, E.E., Carpentier, A.C. (2012). Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans. Diabetes. DOI
• Bosch, J., Gerstein, H.C., Dagenais, G.R., Díaz, R., Dyal, L., Jung, H., Maggiono, A.P., Probstfield, J., Ramachandran, A., Riddle, M.C., Rydén, L.E., Yusuf, S., Richardson, L., Diaz, R., Johnston, P., Vige, R., Birkeland, K., Budaj, A., Cardona, E., ... Urbaneja, H. (2012). N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. New England Journal of Medicine. DOI
• Arguin, H., Dionne, I.J., Sénéchal, M., Bouchard, D.R., Carpentier, A.C., Ardilouze, J.-L., Tremblay, A., Leblanc, C., Brochu, M. (2012). Short- and long-term effects of continuous versus intermittent restrictive diet approaches on body composition and the metabolic profile in overweight and obese postmenopausal women: A pilot study. Menopause. DOI
• Sotornik, R., Brassard, P., Martin, E., Yale, P., Carpentier, A.C., Ardilouze, J.-L. (2012). Update on adipose tissue blood flow regulation. American Journal of Physiology Endocrinology and Metabolism. DOI
• Gagnon, C., Brown, C., Couture, C., Kamga-Ngande, C.N., Hivert, M.F., Baillargeon, J.P., Carpentier, A.C., Langlois, M.F. (2011). A cost-effective moderate-intensity interdisciplinary weight-management programme for individuals with prediabetes. Diabetes and Metabolism. DOI
• Carpentier, A.C., Labbé, S.M., Grenier-Larouche, T., Noll, C. (2011). Abnormal dietary fatty acid metabolic partitioning in insulin resistance and Type 2 diabetes. Clinical Lipidology. DOI
• Langlois, F., Langlois, M.-F., Carpentier, A.C., Brown, C., Lemieux, S., Hivert, M.-F. (2011). Ghrelin levels are associated with hunger as measured by the Three-Factor Eating Questionnaire in healthy young adults. Physiology and Behavior. DOI
• Giacca, A., Xiao, C., Oprescu, A.I., Carpentier, A.C., Lewis, G.F. (2011). Lipid-induced pancreatic β-cell dysfunction: Focus on in vivo studies. American Journal of Physiology Endocrinology and Metabolism. DOI
• Labbé, S.M., Croteau, E., Grenier-Larouche, T., Frisch, F., Ouellet, R., Langlois, R., Guérin, B., Turcotte, E.E., Carpentier, A.C. (2011). Normal postprandial nonesterified fatty acid uptake in muscles despite increased circulating fatty acids in type 2 diabetes. Diabetes. DOI
• Labbé, S.M., Grenier-Larouche, T., Croteau, E., Normand-Lauzière, F., Frisch, F., Ouellet, R., Guérin, B., Turcotte, E.E., Carpentier, A.C. (2011). Organ-specific dietary fatty acid uptake in humans using positron emission tomography coupled to computed tomography. American Journal of Physiology Endocrinology and Metabolism. DOI
• Ouellet, V., Routhier-Labadie, A., Bellemare, W., Lakhal-Chaieb, L., Turcotte, E., Carpentier, A.C., Richard, D. (2011). Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans. Journal of Clinical Endocrinology and Metabolism. DOI
• Martin, E., Brassard, P., Gagnon-Auger, M., Yale, P., Carpentier, A.C., Ardilouze, J.-L. (2011). Subcutaneous adipose tissue metabolism and pharmacology: A new investigative technique. Canadian Journal of Physiology and Pharmacology. DOI
• Sénéchal, M., Arguin, H., Bouchard, D.R., Carpentier, A.C., Ardilouze, J.L., Dionne, I.J., Brochu, M. (2011). Weight gain since menopause and its associations with weight loss maintenance in obese postmenopausal women. Clinical Interventions in Aging. DOI
• Ménard, S.L., Croteau, E., Sarrhini, O., Gélinas, R., Brassard, P., Ouellet, R., Bentourkia, M., Van Lier, J.E., Des Rosiers, C., Lecomte, R., Carpentier, A.C. (2010). Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats. American Journal of Physiology Endocrinology and Metabolism. DOI
• Asghari, S., Courteau, J., Drouin, C., Grégoire, J.-P., Carpentier, A.C., Pâquet, M., Vanasse, A. (2010). Adherence to vascular protection drugs in diabetic patients in Quebec: A population-based analysis. Diabetes and Vascular Disease Research. DOI
• Gagnon, C., Ménard, J., Bourbonnais, A., Ardilouze, J.-L., Baillargeon, J.-P., Carpentier, A.C., Langlois, M.-F. (2010). Comparison of foot-to-foot and hand-to-foot bioelectrical impedance methods in a population with a wide range of body mass indices. Metabolic Syndrome and Related Disorders. DOI
• Richard, D., Carpentier, A.C., Doré, G., Ouellet, V., Picard, F. (2010). Determinants of brown adipocyte development and thermogenesis. International Journal of Obesity. DOI
• Croteau, E., Lavallée, É., Labbe, S.M., Hubert, L., Pifferi, F., Rousseau, J.A., Cunnane, S.C., Carpentier, A.C., Lecomte, R., Bénard, F. (2010). Image-derived input function in dynamic human PET/CT: Methodology and validation with 11C-acetate and 18F- fluorothioheptadecanoic acid in muscle and 18F-fluorodeoxyglucose in brain. European Journal of Nuclear Medicine and Molecular Imaging. DOI
• Normand-Lauziére, F., Frisch, F., Labbé, S.M., Bherer, P., Gagnon, R., Cunnane, S.C., Carpentier, A.C. (2010). Increased postprandial nonesterified fatty acid appearance and oxidation in type 2 diabetes is not fully established in offspring of diabetic subjects. Plos One. DOI
• Sénéchal, M., Arguin, H., Bouchard, D.R., Carpentier, A.C., Ardilouze, J.-L., Dionne, I.J., Brochu, M. (2010). Interindividual variations in resting metabolic rate during weight loss in obese postmenopausal women. A pilot study. Metabolism Clinical and Experimental. DOI
• Carpentier, A.C., Bourbonnais, A., Frisch, F., Giacca, A., Lewis, G.F. (2010). Plasma nonesterified fatty acid intolerance and hyperglycemia are associated with intravenous lipid-induced impairment of insulin sensitivity and disposition index. Journal of Clinical Endocrinology and Metabolism. DOI
• Genest, J., McPherson, R., Frohlich, J., Anderson, T., Campbell, N., Carpentier, A., Couture, P., Dufour, R., Fodor, G., Francis, G.A., Grover, S., Gupta, M., Hegele, R.A., Lau, D.C., Leiter, L., Lewis, G.F., Lonn, E., Mancini, G.B.J., Ng, D., ... Ur, E. (2009). 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Canadian Journal of Cardiology. DOI
• Kamga-Ngandé, C.N., Carpentier, A.C., Nadeau-Marcotte, F., Ardilouze, J.-L., Baillargeon, J.-P., Bellabarba, D., Houde, G., Langlois, M.-F. (2009). Effectiveness of a multidisciplinary program for management of obesity: The Unité d'Enseignement, de Traitement et de Recherche sur l'Obésité (UETRO) database study. Metabolic Syndrome and Related Disorders. DOI
• Ménard, S.L., Ci, X., Frisch, F., Normand-Lauzière, F., Cadorette, J., Ouellet, R., Lier, J.E., Bénard, F., Bentourkia, M., Lecomte, R., Carpentier, A.C. (2009). Mechanism of reduced myocardial glucose utilization during acute hypertriglyceridemia in rats. Molecular Imaging and Biology. DOI
• Asghari, S., Courteau, J., Carpentier, A.C., Vanasse, A. (2009). Optimal strategy to identify incidence of diagnostic of diabetes using administrative data. BMC Medical Research Methodology. DOI
• Lavoie, F., Frisch, F., Brassard, P., Normand-Lauziére, F., Cyr, D., Gagnon, R., Drouin, R., Baillargeon, J.-P., Carpentier, A.C. (2009). Relationship between total and high molecular weight adiponectin levels and plasma nonesterified fatty acid tolerance during enhanced intravascular triacylglycerol lipolysis in men. Journal of Clinical Endocrinology and Metabolism. DOI
• Beriault, K., Carpentier, A.C., Gagnon, C., Ménard, J., Baillargeon, J.-P., Ardilouze, J.-L., Langlois, M.-F. (2009). Reproducibility of the 6-minute walk test in obese adults. International Journal of Sports Medicine. DOI
• Vanasse, A., Carpentier, A.C., Courteau, J., Asghari, S. (2009). Stroke and cardiovascular morbidity and mortality associated with rosiglitazone use in elderly diabetic patients. Diabetes and Vascular Disease Research. DOI
• Arguin, H., Bouchard, D.R., Labonté, M., Carpentier, A., Ardilouze, J.-L., Dionne, I.J., Brochu, M. (2008). Correlation between the rate of weight loss and changes in body composition in obese postmenopausal women after 5 weeks: A pilot study. Applied Physiology Nutrition and Metabolism. DOI
• Brassard, P., Frisch, F., Lavoie, F., Cyr, D., Bourbonnais, A., Cunnane, S.C., Patterson, B.W., Drouin, R., Baillargeon, J.-P., Carpentier, A.C. (2008). Impaired plasma nonesterified fatty acid tolerance is an early defect in the natural history of type 2 diabetes. Journal of Clinical Endocrinology and Metabolism. DOI
• Carpentier, A.C. (2008). Postprandial fatty acid metabolism in the development of lipotoxicity and type 2 diabetes. Diabetes and Metabolism. DOI
• Gerstein, H.C., Yusuf, S., Riddle, M., Ryden, L., Bosch, J., Richardson, L., Dagenais, G., Diaz, R., Johnston, P., Maggioni, A., Probstfield, J., Ramachandran, A., Birkeland, K., Budaj, A., Cardona, E., Chazova, I., Commerford, P., Danilova, L., Davies, M., ... Wittes, J. (2008). Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). American Heart Journal. DOI
• Baillargeon, J.-P., Carpentier, A.C. (2008). Reply: Correlates between hyperinsulinism and hyperandrogenemia?. Fertility and Sterility. DOI
• Roberge, C., Carpentier, A.C., Langlois, M.-F., Baillargeon, J.-P., Ardilouze, J.-L., Maheux, P., Gallo-Payet, N. (2007). Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity. American Journal of Physiology Endocrinology and Metabolism. DOI
• Baillargeon, J.-P., Carpentier, A.C. (2007). Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects. Diabetologia. DOI
• Baillargeon, J.-P., Carpentier, A., Donovan, D., Fortin, M., Grant, A., Simoneau-Roy, J., St-Cyr-Tribble, D., Xhignesse, M., Langlois, M.-F. (2007). Integrated obesity care management system -implementation and research protocol. BMC Health Services Research. DOI
• Leboeuf, R., Perron, P., Carpentier, A.C., Verreault, J., Langlois, M.-F. (2007). L-T3 preparation for whole-body scintigraphy: A randomized-controlled trial. Clinical Endocrinology. DOI
• Carpentier, A.C., Frisch, F., Brassard, P., Lavoie, F., Bourbonnais, A., Cyr, D., Giguère, R., Baillargeon, J.-P. (2007). Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans. American Journal of Physiology Endocrinology and Metabolism. DOI
• Brassard, P., Larbi, A., Grenier, A., Frisch, F., Fortin, C., Carpentier, A.C., Fülöp, T. (2007). Modulation of T-cell signalling by non-esterified fatty acids. Prostaglandins Leukotrienes and Essential Fatty Acids. DOI
• Hivert, M.-F., Langlois, M.-F., Bérard, P., Cuerrier, J.-P., Carpentier, A.C. (2007). Prevention of weight gain in young adults through a seminar-based intervention program. International Journal of Obesity. DOI
• Baillargeon, J.-P., Carpentier, A. (2007). Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fertility and Sterility. DOI
• Hivert, M.-F., Langlois, M.-F., Carpentier, A.C. (2007). The entero-insular axis and adipose tissue-related factors in the prediction of weight gain in humans. International Journal of Obesity. DOI
• Xiao, C., Giacca, A., Carpentier, A., Lewis, G.F. (2006). Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia. DOI
• Turcotte, E., Leblanc, M., Carpentier, A., Bénard, F. (2006). Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18]fluoro-d-glucose injection following I.V. insulin in diabetic patients. Molecular Imaging and Biology. DOI
• Carpentier, A.C., Fülöp, T. (2006). Reply to GJ Wanten [2]. American Journal of Clinical Nutrition. DOI
• Ci, X., Frisch, F., Lavoie, F., Germain, P., Lecomte, R., Lier, J.E., Bénard, F., Carpentier, A.C. (2006). The effect of insulin on the intracellular distribution of 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid in rats. Molecular Imaging and Biology. DOI
• Fulop, T., Tessier, D., Carpentier, A. (2006). The metabolic syndrome. Pathologie Biologie. DOI
• Larbi, A., Grenier, A., Frisch, F., Douziech, N., Fortin, C., Carpentier, A.C., Fülöp, T. (2005). Acute in vivo elevation of intravascular triacylglycerol lipolysis impairs peripheral T cell activation in humans. American Journal of Clinical Nutrition. DOI
• Carpentier, A., Patterson, B.W., Uffelman, K.D., Salit, I., Lewis, G.F. (2005). Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-infected individuals. Atherosclerosis. DOI
• Carpentier, A.C., Frisch, F., Cyr, D., Généreux, P., Patterson, B.W., Giguère, R., Baillargeon, J.-P. (2005). On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans. American Journal of Physiology Endocrinology and Metabolism. DOI
• Leung, N., Sakaue, T., Carpentier, A., Uffelman, K., Giacca, A., Lewis, G.F. (2004). Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men. Diabetologia. DOI
• Ouzilleau, C., Roy, M.-A., Leblanc, L., Carpentier, A., Maheux, P. (2003). An observational study comparing 2-hour 75-g oral glucose tolerance with fasting plasma glucose in pregnant women: Both poorly predictive of birth weight. CMAJ Canadian Medical Association Journal.
• Carpentier, A., Zinman, B., Leung, N., Giacca, A., Hanley, A.J.G., Harris, S.B., Hegele, R.A., Lewis, G.F. (2003). Free fatty acid-mediated impairment of glucose-stimulated insulin secretion in nondiabetic Oji-Cree individuals from the Sandy Lake community of Ontario, Canada: A population at very high risk for developing type 2 diabetes. Diabetes. DOI
• Lam, T.K.T., Carpentier, A., Lewis, G.F., Van de Werve, G., Fantus, I.G., Giacca, A. (2003). Mechanisms of the free fatty acid-induced increase in hepatic glucose production. American Journal of Physiology Endocrinology and Metabolism. DOI
• Carpentier, A., Taghibiglou, C., Leung, N., Szeto, L., Van Iderstine, S.C., Uffelman, K.D., Buckingham, R., Adeli, K., Lewis, G.F. (2002). Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. Journal of Biological Chemistry. DOI
• Lewis, G.F., Carpentier, A., Adeli, K., Giacca, A. (2002). Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocrine Reviews. DOI
• Carpentier, A., Patterson, B.W., Leung, N., Lewis, G.F. (2002). Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans. Diabetes. DOI
• Carpentier, A., Giacca, A., Lewis, G.F. (2001). Effect of increased plasma non-esterified fatty acids (NEFAs) on arginine-stimulated insulin secretion in obese humans. Diabetologia. DOI
• Taghibiglou, C., Carpentier, A., Van Iderstine, S.C., Chen, B., Rudy, D., Aiton, A., Lewis, G.F., Adeli, K. (2001). Erratum: Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular apoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model (Journal of Biological Chemistry (2000) 275 (8416-8425)). Journal of Biological Chemistry.
• Carpentier, A., Patterson, B.W., Uffelman, K.D., Giacca, A., Vranic, M., Cattral, M.S., Lewis, G.F. (2001). The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism. Diabetes. DOI
• Bigam, D.L., Pennington, J.J., Carpentier, A., Wanless, I.R., Hemming, A.W., Croxford, R., Greig, P.D., Lilly, L.B., Heathcote, J.E., Levy, G.A., Cattral, M.S. (2000). Hepatitis C-related cirrhosis: A predictor of diabetes after liver transplantation. Hepatology. DOI
• Taghibiglou, C., Carpentier, A., Van Iderstine, S.C., Chen, B., Rudy, D., Aiton, A., Lewis, G.F., Adeli, K. (2000). Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. Journal of Biological Chemistry. DOI
• Cattral, M.S., Bigam, D.L., Hemming, A.W., Carpentier, A., Greig, P.D., Wright, E., Cole, E., Donat, D., Lewis, G.F. (2000). Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: Clinical outcome of 40 consecutive transplant recipients. Annals of Surgery. DOI
• Carpentier, A., Mittelman, S.D., Bergman, R.N., Giacca, A., Lewis, G.F. (2000). Prolonged elevation of plasma free fatty acids impairs pancreatic β- cell function in obese nondiabetic humans but not in individuals with type 2. Diabetes. DOI
• Lemieux, S., Patterson, B.W., Carpentier, A., Lewis, G.F., Steiner, G. (1999). A stable isotope method using a [2H5]glycerol bolus to measure very low density lipoprotein triglyceride kinetics in humans. Journal of Lipid Research. DOI
• Carpentier, A., Mittelman, S.D., Lamarche, B., Bergman, R.N., Giacca, A., Lewis, G.F. (1999). Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. American Journal of Physiology Endocrinology and Metabolism. DOI
• Lewis, G.F., Carpentier, A., Bilinski, D., Giacca, A., Vranic, M. (1999). Counterregulatory response to hypoglycemia differs according to the insulin delivery route, but does not affect glucose production in normal humans. Journal of Clinical Endocrinology and Metabolism. DOI
• Staudenherz, A., Leitha, T., Carpentier, A., Jeannotte, S., Verreault, J., Lefebvre, B., Bisson, G., Mongeau, C.-J., Maheux, P. (1999). Is there a relationship between 99mTc-sestamibi uptake and oxyphil cell content in hyperparathyroidism? [2] (multiple letters). Journal of Nuclear Medicine.
• Lewis, G.F., Carpentier, A., Vranic, M., Giacca, A. (1999). Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes. Diabetes. DOI
• Lamarche, B., Uffelman, K.D., Carpentier, A., Cohn, J.S., Steiner, G., Barrett, P.H., Lewis, G.F. (1999). Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. Journal of Clinical Investigation. DOI
• Carpentier, A., Jeannette, S., Verreault, J., Lefebvre, B., Bisson, C., Mongeau, C.-J., Maheux, P. (1998). Preoperative localization of parathyroid lesions in hyperparathyroidism: Relationship between technetium-99m-MIBI uptake and oxyphil cell content. Journal of Nuclear Medicine.
• Carpentier, A., Couture, P., Brun, L.-D., Gagné, C. (1998). Severe debilitating xanthomatosis in a French-Canadian patient with heterozygous familial hypercholesterolemia. Endocrinologist. DOI

Chapitres de livre

• Neeland, I.J., Després, J.-P., Carpentier, A.C., Poirier, P. (2023). Indicators of Central Adiposity: A Critical Evaluation of Their Usefulness. Handbook of Obesity Volume 2 Clinical Applications Fifth Edition. DOI
• Fulop, T., Larbi, A., Tessier, D., Carpentier, A. (2006). Diabetes and Aging. Handbook of Models for Human Aging. DOI

Articles de conférence

• Hogan-Lamarre S, Lepitre M, Le Roux E, Sanchez-Delgado G*, Frisch F, Richard G, Noll C, Mampuya W, Phoenix S, Fortin M, Bouffard L, Hoeks J, Schrauwen P, Guérin B, Turcotte EE, Carpentier AC, Blondin DP. (2025). Acute and Chronic Effects of High-Intensity Interval Training on Organ-Specific Dietary Fatty Acid Partitioning in Individuals with Prediabetes. European Association for the Study of Diabetes conference 2025.
• 348. Le Roux E, Hogan-Lamarre S, Lepitre M, Sanchez-Delgado G*, Frisch F, Richard G, Noll C, Mampuya W, Phoenix S, Fortin M, Bouffard L, Guérin B, Turcotte EE, Hoeks J, Schrauwen P, Carpentier AC, Blondin DP. (2025). Acute and training effects of high-intensity exercise on lean and adipose tissue fatty acid fluxes in individuals with prediabetes: preliminary results. European Association for the Study of Diabetes conference 2025.
• Le Roux E, Hogan-Lamarre S, Lepitre M, Sanchez-Delgado G*, Frisch F, Richard G, Noll C, Mampuya W, Phoenix S, Fortin M, Bouffard L, Hoeks J, Schrauwen P, Guérin B, Turcotte EE, Carpentier AC, Blondin D. (2025). Acute and training effects of high-intensity exercise on liver, myocardium and kidney free fatty acid metabolism in prediabetic individuals: preliminary results. Réunion Scientifique 2025 de la Société Québécoise de Lipidologie, de Nutrition et de Métabolisme (SQLNM) et du réseau de recherche en Santé Cardiométabolique, Diabète et Obésité (CMDO).
• Noll C, Frisch F, Bouffard L, Phoenix S, Cunnane CS, Guérin B, Turcotte EE, Malo F-C, Carpentier AC. (2025). Impact de la chirurgie bariatrique sur la source d'acide gras dans le foie14 jours post-opératoire. Réunion Scientifique 2025 de la Société Québécoise de Lipidologie, de Nutrition et de Métabolisme (SQLNM) et du réseau de recherche en Santé Cardiométabolique, Diabète et Obésité (CMDO).
• Noll C, Frisch F, Bouffard L, Phoenix S, Cunnane SC, Guérin B, Turcotte EE, Malo F-C, Carpentier AC. (2025). Impact of Sleeve Gastrectomy on Hepatic and Cardiac Postprandial Fatty Acid Metabolism 14 Days After Surgery. European Association for the Study of Diabetes conference 2025.
• 344. Hogan-Lamarre S, Grandmont M-A, Lepitre M, Le Roux E, Sanchez-Delgado G*, Frisch F, Richard G, Noll C, Mampuya W, Phoenix S, Fortin M, Bouffard L, Hoeks J, Schrauwen P, Guérin B, Turcotte EE, Carpentier AC, Blondin D. (2025). Répartition des acides gras alimentaires en fonction des organes en réponse à un entrainement par intervalles de haute intensité chez des personnes atteintes de prédiabète. Réunion Scientifique 2025 de la Société Québécoise de Lipidologie, de Nutrition et de Métabolisme (SQLNM) et du réseau de recherche en Santé Cardiométabolique, Diabète et Obésité (CMDO).
• 343. Lepitre M, Hogan-Lamarre S, Le Roux E, Sanchez-Delgado G*, Frisch F, Richard G, Noll C, Mampuya W, Phoenix S, Fortin M, Bouffard L, Hoeks J, Schrauwen P, Guérin B, Turcotte EE, Carpentier AC, Blondin D. (2025). Réponse cardiométabolique d'un programme d'exercice par intervalles à haute intensité chez une population vivant avec le prédiabète. Réunion Scientifique 2025 de la Société Québécoise de Lipidologie, de Nutrition et de Métabolisme (SQLNM) et du réseau de recherche en Santé Cardiométabolique, Diabète et Obésité (CMDO).
• 346. Kotte M, de Kam S, Habets I, Timmermans M, van de Weijer T, Blondin DP, Carpentier AC, Schrauwen P, Hoeks J. (2025). The Impact of Acute AM vs. PM Exercise on Nocturnal Energy and Substrate Metabolism in Individuals at Risk for Developing Type 2 Diabetes. European Association for the Study of Diabetes conference 2025.
• Sanchez-Delgado G, Dumont L, Noll C, Richard G, Frisch F, Fortin M, Phoenix S, Lepage M, Guérin B, Turcotte EE, Blondin DP, Carpentier AC. (2024). A single dose of theB2-adrenergic receptor agonist formoterol does not increase oxidativemetabolism of brown adipose tissue in healthy patients. European Association of the Study of Diabetes conference 2024.
• Dion D, Noll C, Fortin M, Haroune L, Saibi S, Sarret P, Carpentier AC. (2024). Les endocanabinoïdescirculants: des biomarqueurs de la function métabolique des tissus adipeuxblancs chez l'humain?. Réunion Scientifique 2024 de la Société Québécoise de Lipidologie, de Nutrition et de Métabolisme (SQLNM) et du réseau de recherche en Santé Cardiométabolique, Diabète et Obésité (CMDO).
• Dion D, Noll C, Fortin M, Haroune L, Saibi S, Sarret P, Carpentier AC. (2024). in vivoLes endocannabinoïdescirculants sont associés avec la function métabolique des tissus adipeux blancs chez l'humain. Journée. Journée scientifique de la Faculté de médecine et des sciences de la santé de l'Université de Sherbrooke.
• Fernandez-Fernandez J, Sanchez-Delgado G, Hogan-Lamarre S, Richard G, Frisch F, Phoenix S, Fortin M, Bouffard L, Noll C, Mampuya W, Guérin B, Turcotte EE, Hoeks J, Schrauwen P, Carpentier AC, Blondin DP. (2023). Does myocardium and liverfractional uptake of circulating fatty acids change after consuming a meal inpeople with prediabetes?. European Association of Nuclear Medicine Conference.
• Noll C, Uy K, Bouyakdan K, Fortin M, Beauchemin S, Phoenix S, Rhéaume E, Alquier T, Tardif JC, Carpentier AC. (2023). L`expression d'Adcy9 dansles plexus choroïdes ou dans les cellules endothéliales module la thermogénèsedu tissu adipeux brun chez la souris. Réunion Scientifique 2023 de la Société Québécoise de Lipidologie, de Nutrition et de Métabolisme (SQLNM) et du réseau de recherche en Santé Cardiométabolique, Diabète et Obésité (CMDO).
• Hogan-Lamarre S, Côté M, Lepitre M, Sanchez-Delgado G, Frisch F, Richard G, Noll C, Mampuya W, Phoenix S, Fortin M, Bouffard L, Hoeks J, Schrauwen P, Guérin B, Turcotte EE, Carpentier AC, Blondin DP. (2023). Postprandial energymetabolism in response to exercise in individuals with prediabetes. Obesity Week 2023.
• Sanchez-Delgado G, Dumont L, Richard G, Frisch F, Fortin M, Phoenix S, Lepage M, Guérin B, Turcotte EE, Blondin DP, Carpentier AC. (2022). -. 2022 Diabetes Canada/CSEM Professional Conference.
• Noll C, Uy K, Bouyakdan K, Fortin M, Beauchemin S, Phoenix S, Rhéaume E, Alquier T, Tardif JC, Carpentier AC. (2022). Adcy9 expression in choroidplexus or endothelial cells modulates brown adipose tissue thermogenesis. Recent Advances & Controversies in the Measurement of Energy Metabolism (RACMEM).
• Sanchez-Delgado G, Richard G, Hogan-Lamarre S, Ivanova Y, Gendreau M, Frisch F, Noll C, Mampuya W, Phoenix S, Fortin M, Bouffard L, Hoeks J, Schrauwen P, Guérin B, Turcotte EE, Carpentier AC, Blondin DP. (2022). Effect of exerciseperformed at different times of the day on postprandial metabolism ofindividuals with prediabetes. Danish Diabetes Academy Postdoctoral Summit 2022.
• Dion D, Noll C, Giguère H, Frégeau G, Sarrhini O, Auger-Messier M, Ong H, Marleau S, Carpentier AC. (2022). Effect of pharmacologicalmodulation of CD36 on total oxidative and nonesterified fatty acid metabolismin a nutritional model of insulin resistance. Recent Advances & Controversies in the Measurement of Energy Metabolism (RACMEM).
• Dion D, Noll C, Fortin M, Haroune L, Saibi S, Sarret P, Carpentier AC. (2022). Les endocanabinoïdes circulants: des biomarqueurs de la function métabolique des tissus adipeuxblancs chez l'humain?. 2022 Scientific Meeting of the SQLNM, the CMDO Network and the Colossus Congress.
• Ye RZ*, Montastier E*, Frisch, F, Noll C, Gévry N, Allard-Chamard H, Tchernof A, Carpentier A. (2022). Single Nuclei RNA-Sequencing of Frozen Human Adipose Tissue and PET/CTImaging Coupled With Deep-Learning Reveals Single-Cell Landscape andTranscriptional Dynamics Related to Adipocyte Hypertrophy and in VivoDysmetabolism (OR23). ENDO 2022.
• Ye RZ, Montastier E, Noll C, Phoenix S, Amrani M, Fortin M, Bouffard L, Frisch F, Turcotte EE, Carpentier AC. (2021). L'augmentation du fluxpostprandial d'acide gras non-estérifié chez les sujets pré-diabétiques estmodérée par une amélioration du captage d'AG dans les tissus adipeux. ACFAS Congress. (2021).
• Ye RZ, Montastier E, Noll C, Phoenix S, Amrani M, Fortin M, Bouffard L, Frisch F, Turcotte EE, Carpentier AC. (2021). L'implication del'hypertrophie adipocytaire dans le métabolisme lipidique systémique in vivochez l'humain. Ye RZ, Montastier E, Noll C, Phoenix S, Amrani M, Fortin M, Bouffard L, Frisch F, Turcotte EE, Carpentier AC.
• Ye RZ*, Phoenix S, Amrani M, Bouffard L, Frisch F, Turcotte EE, Montastier E*, Noll C, Carpentier AC. (2020). 1866-P | Adipocyte Hypertrophy Is Associated withIncreased Dietary Fatty Acid Storage in Adipose Tissue and Reduced PostprandialHepatic Fatty Acid Uptake and Esterification in Humans. American Diabetes Association Virtual 80th Scientific Sessions.
• Montastier E, Noll C, Ye RZ, Amrani M, Frisch F, Fortin M, Bouffard L, Phoenix S, Cunnane SC, Guérin B, Turcotte EE, Carpentier AC. (2020). Effet de l'inhibition pharmacologique de la lipolyse adipocytaire sur le métabolisme post-prandial des acides gras alimentaires. 2020 Scientific Meeting of the SQLNM, the CMDO Network and the Colossus Congress.
• Dion D, Noll C, Giguère H, Frégeau G, Sarrhini O, Auger-Messier M, Ong H, Marleau S, Carpentier AC. (2020). Effet de la modulation deCD36 sur le métabolisme oxydatif et des acides gras non-estérifiés dans unmodèle nutritionnel de résistance à l'insuline. 2020 Scientific Meeting of the SQLNM, the CMDO Network and the Colossus Congress.
• Richard G, Noll C, Archambault M, Lebel R, Tremblay L, Ait-Mohand S, Carpentier AC, Lepage M. (2020). Estimation of brown adiposetissue perfusion by DCE-MRI improves measurement of oxidative metabolism by11C-acetate PET in a rat model. ISMRM Annual Meeting.
• Richard G, Blondin DP, Frisch F, Fortin M, Thibodeau C, Dubreuil S, Noll C, Lepage M, Carpentier AC. (2020). Organ-specific metabolicchanges induced by a high fructose diet. Imagining Imaging Symposium.
• Montastier E*, Noll C, Ye RZ*, Amrani M, Frisch F, Fortin M, Bouffard L, Sarrhini O, Phoenix S, Cunnane SC, Guérin B, Turcotte EE, Carpentier AC. (2020). The Effect of Inhibition of Fatty Acid Spillover from Adipose Tissues onOrgan-Specific Distribution of Dietary Fatty Acids. American Diabetes Association Virtual 80th Scientific Sessions.
• Ye RZ, Montastier E, Noll C, Phoenix S, Amrani M, Fortin M, Bouffard L, Frisch F, Turcotte EE, Carpentier AC. (2020). The implication of humanadipocyte hypertrophy in in vivo systemic lipid metabolism and insulinresistance. 2020 Scientific Meeting of the SQLNM, the CMDO Network and the Colossus Congress.
• Richard G, Blondin DP, Noll C, Lebel R, Lepage M, Carpentier AC. (2019). Advanced 11C-acetatekinetic modeling for brown adipose tissue assessment''. Saltin InternationalCourse in Exercise and Clinical Physiology. Saltin International Course in Exercise and Clinical Physiology.
• Dion D, Noll C, Giguère H, Frégeau G, Sarrhini O, Auger-Messier M, Ong H, Marleau S, Carpentier AC. (2019). Effet de la modulation deCD36 sur le métabolisme oxydatif et des acides gras non-estérifiés dans unmodèle nutritionnel de résistance à l'insuline. Journée scientifique de la Faculté de médecine et des sciences de la santé de l'Université de Sherbrooke.
• Turcotte AF, Grenier-Larouche T*, Carreau AM*, Carpentier AC, Mac-Way F, Tchernof A, Richard D, Biertho L, Lebel S, Marceau S, Ferron M, Gagnon C. (2019). Improvement in Glucose Homeostasis After Biliopancreatic Diversion isAssociated with Increased Uncarboxylated Osteocalcin. 24th World Congress of International Federation for the Surgery of Obesity.
• Richard G, Blondin DP, Noll C, Lebel R , Lepage M , Carpentier AC. (2019). Kinetic modeling of11C-acetate in brown adipose tissue. RBIQ.
• Ye RZ, Montastier E, Noll C, Phoenix S, Amrani M, Fortin M, Bouffard L, Frisch F, Turcotte EE, Carpentier AC. (2019). The implication of humanadipocyte hypertrophy in in vivo systemic lipid metabolism and insulinresistance. Journée Phare 2019, congrès québécois en sciences de la santé (Quebec congress in health sciences).
• Carreau AM*, Noll C, Guérin B, Biertho L, Turcotte EE, Tchernof A, Carpentier AC. (2018). Early effects of sleeve gastrectomy (SC) on systemic and organ-specific dietary fatty acid uptake, postprandial free fatty acids (FFA), and glucose metabolism in type 2 diabetes (T2D). American Diabetes Association's 78th Scientific Sessions. DOI
• Turcotte AF, Grenier-Larouche T*, Ung RV, Carreau AM*, Carpentier AC, Mac-Way F, Gagnon C. (2018). Effects of biliopancreatic division on bone turnover markers and association with hormonal factors inpatients with severe obesity. Journée de la recherché en santé de l'Université de Laval.
• Turcotte AF, Grenier-Larouche T* Ung RV, Carreau AM*, Carpentier AC, Mac-Way F, Gagnon C. (2018). Effects of biliopancreaticdivision on bone turnover markers and association with hormonal factors inpatients with severe obesity. 2nd Canadian Musculoskeletal Conference.
• Carreau AM*, Nadeau M, Noll C, Frisch F, Bouffard L, Phoenix S, Guérin B, Biertho L, Tchernof A, Carpentier AC. (2017). Effets précoces de la gastrectomie pariétale (GP) sur la métabolisme prostprandial des lipides alimentaires. 6e Journée scientifique de l'Axe/Thème/Centre d'excellence de l'Université de Sherbrooke en Diabète, Obésité et complications cardiovasculaires (DOCC).
• Grenier-Larouche T*, White PJ, Biertho L, Kwee L, Shah S, Carpentier AC, Newgard CB, Tchernof A. (2017). Interaction entre le métabolisme des lipides et des acides aminés dans le développement de la maladie hépatique non alcoolique. Réunion scientifique annuelle 2017 de la SQLNM, du Réseau CMDO et du Congrès COLosSUS.
• Chénard T*, Carpentier AC, Tchernof A, Najmanovich R. (2017). Modulation du métabolisme de l'adipocyte pour prévenir le diabète de type 2 : une analyse in silico du réseau iTC1390adip. Réunion scientifique annuelle 2017 de la SQLNM, du Réseau CMDO et du Congrès COLosSUS.
• Noll C, Kunach M*, Frisch F, Bouffard L, Dubreuil S, Phoenix S, Cunnane SC, Guérin B, Turcotte EE, Laville M, Carpentier AC. (2017). Une surnutrition de 7 jours diminue la répartition des acides gras postprandiaux au niveau du myocarde chez des sujets en santé. Réunion scientifique annuelle 2017 de la SQLNM, du Réseau CMDO et du Congrès COLosSUS.
• Chénard T*, Carpentier AC, Tchernof A, Najmanovich R. (2017). Validation expérimentale de gènes prédits comme affectant le métabolisme des adipocytes dans le diabète de type 2. 6e Journée scientifique de l'Axe/Thème/Centre d'excellence de l'Université de Sherbrooke en Diabète, Obésité et complications cardiovasculaires (DOCC).
• Noll C, Auger-Messier M, Geraldes P, Baillargeon JP, Dumaine R, Leduc R, Benrezzak O, Carpentier AC. (2016). Analyse du transcriptome et de la dépense énergétique quotidienne dans un modèle de rat de résistance à l'insuline. 5e Journée scientifique Axe/Thème et Centre d'excellence de l'Université de Sherbrooke (CEUS) en Diabète, obésité et complications cardiovasculaires (DOCC).
• Blondin DP*, Labbé SM, Phoenix S, Guérin B, Turcotte EE, Richard D, Carpentier AC. (2016). Contributions of white and brown adipose tissues and skeletal muscles to cold-induced metabolic responses. Obesity Week 2016.
• Noll C, Kunach M, Frisch F, Bouffard L, Dubreuil S, Phoenix S, Guérin B, Turcotte EE, Carpentier AC. (2016). Effet d'une surnutrition de 7 jours sur le métabolisme postprandial des acides gras alimentaires chez des sujets en santé. Réunion annuelle SQLNM/ CMDO/ COLosSUS.
• Carreau AM, Noll C, Nadeau M, Biertho L, Richard D, Tchernof A, Carpentier AC. (2016). Effets précoces de la gastrectomie pariétale(GP) et de la dérivation biliopancréatique avec commutation duodénale (DBP-CD) sur le métabolisme postprandial des lipides. Réunion annuelle SQLNM/ CMDO/ COLosSUS.
• Chénard T*, Carpentier AC,Tchernof A, Najmanovich R. (2016). L'utilisation d'un réseau métabolique d'adipocyte dans l'étude de mécanismes menant au développement du diabète de type 2. 5e Journée scientifique Axe/Thème et Centre d'excellence de l'Université de Sherbrooke (CEUS) en Diabète, obésité et complications cardiovasculaires (DOCC).
• Chénard T*, Carpentier AC, Tchernof A, Najamanovich R. (2016). L'utilisation d'un réseau métabolique d'adipocytes humains dans l'étude du métabolisme des lipides dans le contexte du développement du diabète de type 2. Réunion annuelle SQLNM/ CMDO/ COLosSUS.
• Blondin D, Phoenix S, Guérin B, Turcotte EE, Haman F, Carpentier A. (2016). Le rôle des triglycérides intracellulaires sur le métabolisme de la graisse brune chez des hommes sains exposés au froid. Réunion annuelle SQLNM/ CMDO/ COLosSUS.
• Grenier-Larouche T*,Careau AM*, Frisch, F,Biertho L, Marceau S, Lebel S, Hould FS, Richard D, Tchernof A, Carpentier AC. (2016). Modifications du métabolisme du glycérol et des acides gras non-estérifiés comme vecteur de rémission du diabète de type 2 en réponse à la chirurgie bariatrique. 5e Journée scientifique Axe/Thème et Centre d'excellence de l'Université de Sherbrooke (CEUS) en Diabète, obésité et complications cardiovasculaires (DOCC).
• Faubert J, Baptiste G. C, Naimi F, Bellanger S, Gallo-Payet N, Battista MC, Benrezzak O, Carpentier AC, Baillargeon JP. (2016). Une surexposition aux acides gras non estérifiés in vivo augmente les niveaux d'androgènes circulant dans un modèle de chiens normaux. 5e Journée scientifique Axe/Thème et Centre d'excellence de l'Université de Sherbrooke (CEUS) en Diabète, obésité et complications cardiovasculaires (DOCC).
• Carreau A-M, Grenier-Larouche T, Biertho L, Tchernof A, Carpentier AC. (2015). Effect of Insulin-Resistance, Diabetes and Biliopancreatic Diversion with Duodenal Switch (BDP-DS) on Acylcarnitines (AC) under Fasting, Postprandial, Hyperinsulinemic and Hyperlipidemic Conditions In Severely Obese Patients. 2015 Professional Conference and 18th Annual Meeting of the CSEM.
• Stroes ES, Bernelot-Moens SJ, Carpentier AC, Frish F, Petry H, Meyer C, Brisson D, Bruno M, Gaudet D. (2015). Gene Therapy for Lipoprotein Lipase Deficiency (LPLD): Learnings From the Clinical Development of Alipogen tiparvovec, an AAV1 therapy for LPLD. 17th Triennial Congress of the International Atherosclerosis Society, ISA 2015.
• Grenier-Larouche T, Frisch F, Caron-Dorval C, Biron S, Hould F, Biertho L, Richard D, Tchernof A, Carpentier A. (2015). Impaired nonesterified fatty acid (NEFA) metabolism in type 2 diabetes (T2D) is rapidly corrected after biliopancreatic diversion with duodenal switch (BPD/DS). 5th ICCR Congress on Chronic Societal Cardiometabolic Diseases.
• Blondin DP, Haman F, Richard D, Carpentier AC, Guérin B, Phoenix S, Turcotte E. (2015). Inhibition of intracellular triglyceride lipolysis significantly impairsBAT oxidative metabolism in humans (oral presentation). 2016 Keystone Symposia Conference.
• Chénard T, Carpentier A, Tchernof A, Najmanovich R. (2015). Lipid metabolism and storage in adipocytes studied via metabolic network linked to the development of type two diabetes. 5th ICCR Congress on Chronic Societal Cardiometabolic Diseases.
• Blondin DP, Noll C, Tingelstad H, Labbé SM, Guérin B, Turcotte EE, Richard D, Haman F, Carpentier, AC. (2015). Postprandial energy metabolism of brown adipose tissue in cold-acclimated humans. Keystone Symposia, 'Beige and Brown Fat: Basic Biology and Novel Therapeutics.
• Noll C, Kunach M, Frisch F, Bouffard L, Dubreuil S, Jean-Denis F, Phoenix S, Guérin B, Turcotte E, Carpentier AC. (2015). Seven-day caloric and saturated fat restriction increases myocardial dietary fatty acid partitioning in impaired glucose-tolerant subjects. 5th ICCR Congress on Chronic Societal Cardiometabolic Diseases.
• Noll C, Kunach M, Frisch F, Bouffard L, Dubreuil S, Jean-Denis F, Phoenix S, Guérin B, Turcotte EE, Carpentier AC. (2015). Un régime hypocalorique et pauvre en acides gras saturés induit une augmentation du captage des acides gras chez des sujets intolérants au glucose en période postprandiale. 4e Journée scientifique du DOCC.
• Kunach M, Noll C, Phoenix S, Guérin B, Baillargeon JP, Turcotte E, Carpentier AC. (2014). Effect of Gender and Impaired Glucose Tolerance on Postprandial Dietary Fatty Acid Metabolism and Myocardial Function in Humans. 74th Scientific Sessions of the American Diabetes Association.
• Kunach M, Noll C, Phoenix S, Guérin B, Baillargeon JP, Turcotte E, Carpentier AC. (2014). Effets du sexe et de l'intolérance au glucose sur le métabolisme des acides gras alimentaires et la fonction cardiaque en période postprandiale chez l'humain. Congrès SQLNM/ CMDO/ COLosSUS 2014.
• Kunach M, Noll C, Phoenix S, Guérin B, Baillargeon JP, Turcotte É, Carpentier AC. (2014). Effets du sexe et de l'intolérance au glucose sur le métabolisme des acides gras alimentaires et la fonction cardiaque en période postprandiale chez l'humain. 3e Journée scientifique du DOCC.
• Noll N, Kunach M, Phoenix S, Turcotte EE, Guérin B, Carpentier AC. (2014). Hepatic metabolism of dietary fatty acids (DFA) in subject with impaired glucose tolerance during postprandial state after a 7-days hypocaloric diet low in saturated fat. 74th Scientific Sessions of the American Diabetes Association.
• Chénard T, Carpentier AC, Tchernof A, Najmanovich R. (2014). L'utilisation de la biologie des systèmes dans l'étude du métabolisme des lipides en lien avec le développement du diabète de type 2. 3e Journée scientifique du DOCC.
• Grenier-Larouche T, Frisch F, Caron-Dorval D, Biron S, Marceau S, Hould F, Lebel S, Biertho L, Tchernof A, Richard D, Carpentier AC. (2014). La diminution des flux d'acides gras plasmatiques participe à l'amélioration du métabolisme du glucose suite à la dérivation biliopancréatique avec commutation duodénale. Congrès SQLNM/ CMDO/ COLosSUS 2014.
• Grenier-Larouche T, Frisch F, Caron-Dorval D, Biron S, Marceau S, Hould FS, Lebel S, Biertho L, Tchernof A, Richard D, Carpentier AC. (2014). Résolution à court terme de l'intolérance aux lipides suite à la dérivation biliopancréatique avec commutation duodénale (DBP-CD). 3e Journée scientifique du DOCC.
• Noll C, Kunach M, Frisch F, Phoenix S, Turcotte EE, Guérin B, Carpentier AC. (2014). Un régime hypocalorique et pauvre en acides gras saturés induit une augmentation du captage des acides gras chez des sujets intolérants au glucose en période postprandiale. Congrès SQLNM/ CMDO/ COLosSUS 2014.
• Noll C, Kunach M, Frisch F, Phoenix S, Turcotte EE, Guérin B, Carpentier AC. (2014). Un régime hypocalorique et pauvre en acides gras saturés induit une augmentation du captage myocardial des acides gras chez des sujets intolérants au glucose en période postprandiale. 3e Journée scientifique du DOCC.
• Chénard T, Carpentier AC, Tchernof A, Najmanovich R. (2014). Utilisation de la biologie des systèmes dans l?étude du métabolisme des lipides en lien avec le développement du diabète de type 2. Congrès SQLNM/ CMDO/ COLosSUS 2014.
• Boutin M, Fortin M, Frisch F, Carpentier AC, Auray-Blais C. (2013). 13C16-Palmitic Acid Metabolization into Ceramide for the Determination of Ceramide Synthesis in Type 2 Diabetes Patients. 9th Annual Conference of the Metabolomics Society.
• Plourde CE, Grenier Larouche T, Caron-Dorval D, Biron S, Lebel S, Tchernof A, Richard D, Carpentier AC. (2013). Biliopancreatic Diversion-induced Rapid Reversal of Beta Cell Dysfunction in Type 2 Diabetes is associated with Caloric Restriction, not improved Incretin Secretion. 73rd ADA Scientific Sessions.
• Gagnon C, Daly RM, Carpentier AC, Lu ZX, Shore-Lorenti C, Sikaris K, Jean S, Ebeling PR. (2013). Effect of Combined Calcium and Vitamin D Supplementation on Insulin Secretion and Insulin Sensitivity in Vitamin D-deficient Adults at High Risk of Type 2 Diabetes. ASBMR 2013 Annual Meeting.
• Dutia R, Brakoniecki K, McGinty J, Ren-Fielding C, Homel P, Rosen D, Koshy N, Harvey EJ, Carpentier AC, Laferrère B. (2013). Effects of Roux-en-Y gastric bypass versus gastric banding on ?-cell function in patients with diabetes after ~10% and ~25% weight loss. The Obesity Society Annual Meeting.
• Kunach M, Noll C, Labbé SM, Grenier-Larouche T, Bouffard L, Phoenix S, Guérin B, Baillargeon JP, Langlois MF, Turcotte EE, Carpentier AC. (2013). Effets des habitudes de vie sur les anomalies du métabolisme postprandial des acides gras alimentaires chez les patients intolérants au glucose. 42e Journée scientifique FMSS, Université de Sherbrooke.
• Kunach M, Noll C, Labbé SM, Grenier-Larouche T, Bouffard L, Phoenix S, Guérin B, Baillargeon JP, Langlois MF, Turcotte EE, Carpentier AC. (2013). Effets des habitudes de vie sur les anomalies du métabolisme postprandial des acides gras alimentaires chez les patients intolérants au glucose. 2e Journée scientifique annuelle du Thème/Axe DOCC.
• Leblanc S, Noll C, Battista MC, Gallo-Payet N, Vine DF, Carpentier AC, Baillargeon JP. (2013). Implication des acides gras non-estérifiés dans l'hyperandrogénie d'un modèle de rat du syndrome des ovaires polykystiques. 2e Journée scientifique annuelle du Thème/Axe DOCC.
• Kunach M, Noll C, Labbé SM, Grenier-Larouche T, Bouffard L, Phoenix S, Guérin B, Baillargeon JP, Langlois MF, Turcotte EE, Carpentier AC. (2013). Improved Cardiopulmonary Functional Capacity Following a One-Year Lifestyle Intervention Regimen Does Not Explain Improved Postprandial Myocardial Dietary Fatty Acid Metabolism in Patients with Impaired Glucose Tolerance. CDA/CSEM Professional Conference & Annual Meetings.
• Veilleux A, Grenier É, Marceau P, Carpentier AC, Richard , Levy É. (2013). Inflammation and oxidative stress in the small intestine are associated with insulin resistance and alterations in lipid homeostasis in obese subjects. Digestive Disease Week 2013.
• Labbé SM, Blondin DP, Noll C, Kunach M, Guérin B. Turcotte EE, Haman F, Carpentier AC, Richard D. (2013). L'exposition aigue au froid n'induit pas l'activation du tissu adipeux brun chez le patient diabétique. 5e Réunion annuelle COLosSUS.
• Chénard T, Carpentier AC, Najmanovich R. (2013). L'utilisation de la biologie des systèmes dans l'analyse du métabolisme des lipides en lien avec le développement du diabèete de type 2. 2e Journée scientifique annuelle du Thème/Axe DOCC.
• Blondin DP, Labbé SM, Turcotte EE, Richard D, Carpentier AC, Haman F. (2013). La contribution thermogénique du tissu adipeux brun augmente suite è un protocole d'acclimatation au froid chez des hommes sains. 5e Réunion annuelle COLosSUS.
• Labbé SM, Baraboi ED, Grenier-Larouche T, Roy MC, Noll C, Li W, Bouchard C, Lecomte R, Carpentier AC, Richard D. (2013). La perte de poids associée è la chirurgie bariatrique n'est pas due à une augmentation de la capacité et du metabolisme du tissu adipeux brun chez le rat. 5e Réunion annuelle COLosSUS.
• Bouchouirab FZ, Fortin M, Dubé J, Carpentier AC. (2013). Le débordement des aclcarnitines dans la circulation n'est pas établi chez les sujets à haut risque de développer un diabète de type 2, mais confirmé chez les diabétiques type 2. 2e Journée scientifique annuelle du Thème/Axe DOCC.
• Plourde CE, Caron-Dorval D, Grenier-Larouche T, Biron S. Richard D, Carpentier AC. (2013). Mécanismes de résolutions précoces du diabète de type 2 (DT2) suivant la dérivation biliopancréatique avec commutation duodénale (DPB/CD). 5e Réunion annuelle COLosSUS.
• Noll C, Labbé SM, Kunach M, Phoenix S, Turcotte EE, Guérin B, Carpentier AC. (2013). Métabolisme postprandial des acides gras alimentaires chez des sujets intolérants au glucose lors d'un régime hypocalorique et pauvre en acides gras saturés. 5e Réunion annuelle COLosSUS.
• Leblanc S, Noll C, Battista MC, Vine DF, Gallo-Payet N, Carpentier AC, Baillargeon JP. (2013). Role of Non-Esterified Fatty Acid in the Hyperandrogenemia of a Rat Model of Polycystic Ovary Syndrome. Endo 2013.
• Grenier-Larouche T, Galinier A, Casteilla L, Michaud A, Carpentier AC, Tchernof A. (2013). Réduction du contenu en coenzyme Q10 et modification du statut redox dans l'obésité et l'hypertrophie adipocytaires des tissus adipeux humains. Congrès SQLNM/CMDO 2013.
• Leblanc S, Noll C, Battista MC, Gallo-Payet N, Vine DF, Carpentier AC, Baillargeon JP. (2013). Rôle des acides gras non-estérifies dans l'hyperandrogenie d'un modèle de rat du syndrome des ovaires polykystiques. 55e Réunion annuelle du CRCQ.
• Leblanc S, Noll C, Battista MC, Gallo-Payet N, Vine DF, Carpentier AC, Baillargeon JP. (2013). Rôle des acides gras non-estérifiés dans l'hyperandrogénie d'un modèle de rat du syndrome des ovaires ploykystiques. Congrès SQLNM-CMDO 2013.
• Leblanc S, Battista MC, Gallo-Payet N, Vine D, Noll C, Carpentier AC, Baillargeon JP. (2013). Rôle des acides gras non-estérifiés dans l'hyperandrogénie d'un modèle de rat du syndrome des ovaires polykystiques. 5e Réunion annuelle COLosSUS.
• Labbe SM, Carpentier AC, Richard D, Lecomte R. (2013). SNS-mediated activation of brown adipose tissue capacity and metabolism. Keystone Symposia Neuronal Control of Appetite, Metabolism and Weight (C6).
• Labbe SM, Baraboi ED, Grenier-Larouche T, Roy MC, Noll C, Li W, Bouchard C, Lecomte R, Carpentier AC, Richard D. (2013). Weight Loss Associated to Bariatric Surgery Was Not Coupled to an Enhanced Activity of Brown Adipose Tissue Capacity and Metabolism in Rodents. 73rd ADA Scientific Sessions.
• Lachance D, Vaillant F, Daneault C, Frayne-Robillard I, Duval F, Deschepper C, Carpentier AC, Tardif JC, Des Rosiers C. (2012). A high fat/high fructose (HF) diet does not exacerbate metabolic or cardiac functional alterations induced by diabetes in mice. 2012 Experimental Biology.
• Plourde CE, Caron-Dorval D, Grenier Larouche T, Biron S, Richard D, Carpentier AC. (2012). Characterisation of glucose homeostasis and caloric restriction early after biliopancreatic diversion with duodenal switch (BPD/DS). 2012 CDA/CSEM Annual Congress.
• Labbé SM, Grenier?Larouche T, Baraboï ED, Noll C, Bouchard C, Shooner J, Carpentier AC, Richard D. (2012). Détermination du partionnement des gras alimentaires suite à une dérivation bilio-pancréatique (DBP) chez le rat. 4e Réunion annuelle de la plate-forme COLosSUS.
• Plourde CE, Caron?Dorval D, Biron S, Marceau S, Lebel S, Laroche S, Carpentier AC, Richard D. (2012). L'évolution temporelle de l'homéostasie du glucose ainsi que la restriction calorique sévère suivant la dérivation biliopancréatique avec commutation duodénale. 4e Réunion annuelle de la plate-forme COLosSUS.
• Twisk J, Frisch F, Sier-Ferreira V, van den Bulk N, Petry H, Carpentier AC, Gaudet D. (2012). Long-term transgene expression and biological activity following IM administration of AAV1-LPLS447X to LPL deficient patients. ASGCT 2012 15th Meeting.
• Johnson-Black P, Bunker P, Embrey M, Paultre F, Carpentier AC, Laferrere B. (2012). Normalization of beta cell glucose sensitivity after gastric bypass in patients with type 2 diabetes (DM). 72nd Scientific Sessions American Diabetes Association.
• Veilleux A, Grenier E, Carpentier AC, Richard D, Lévy E. (2012). Perturbation du métabolisme lipidique dans l'intestin de patients obèses et insulino-résistants. 13e Réunion annuelle de la SQLNM.
• Bilodeau S, Hivert MF, Xhignesse M, Brown C, Carpentier AC, Langlois MF. (2012). Peut-on augmenter la compétence des médecins dans le soutien au changement des habitudes de vie ?. 4e Réunion annuelle de la plateforme COLosSUS.
• Lacerte G, Lacroix M, Doyon M, Brown C, Carpentier AC, Langlois MF, Hivert MF. (2012). Physiopathologie du gain de poids chez les jeunes adultes : lien entre le gain de poids, les changements de sensibilité à l'insuline et les niveaux sanguins d'adiponectine. 13e Réunion annuelle de la SQLNM.
• Lacerte G, Lacroix M, Doyon M, Brown C, Carpentier AC, Langlois MF, Hivert MF. (2012). Physiopathologie du gain de poids chez les jeunes adultes : liens entre le gain de poids, les changements de sensibilité à l'insuline et les niveaux circulants d'adiponectine. 1re Journée scientifique de l'Axe/Thème Diabète, Obésité et Complications Cardiovasculaires.
• Bunker P, Johnson-Black P, Carpentier AC, Wang G, Agenor K, Paultre P, Embrey M, Obrien C, ColarussoA, Laferrère B. (2012). Prehepatic insulin secretion rate 3 years after GBP in patients with T2DM. 30th Annual Scientific Meeting Obesity Society 2012.
• Plourde CE, Caron-Dorval D, Biron S, Richard D, Carpentier AC. (2012). Rapid improvement of triglyceride but not nonesterified fatty acid metabolism may contribute to rapid improvement of glucose homeostasis after biliopancreatic diversion with duodenal switch (BPD/DS). XVII World Congress IFSO 2012.
• Grenier-Larouche T, Labbé SM, Noll C, Carpentier AC. (2012). Redistribution des flux d'acides gras suite à un traitement au 4?phénylbutyrate dans un modèle nutritionnel de diabète de type 2. 4e Réunion annuelle de la plate-forme COLosSUS.
• Grenier-Larouche T, Labbé SM, Noll C, Carpentier AC. (2012). Regulation of nonesterified fatty acid metabolism by sodium 4-phenybutyrate in a nutritional model of type 2 diabetes. 2012 CDA/CSEM Annual Congress.
• Forget G, Doyon M, Lacerte G, Labonté M, Brown C, Carpentier AC, Langlois MF, Hivert MF. (2012). Très faible prévalence d'une alimentation idéale et d'une santé cardiovasculaire idéale telles que définies par l'American Heart Association chez les jeunes adultes. 1re Journée scientifique de l'Axe/Thème Diabète, Obésité et Complications Cardiovasculaires.
• Caron-Dorval D, Plourde CÉ, Biron S, Marceau S, Biertho L, Richard D, Carpentier AC. (2012). Évolution de l'homéostasie du glucose et restriction calorique sévère suivant la chirurgie bariatrique par DBP/CD. 13e Réunion annuelle de la SQLNM.
• Grenier-Larouche T, Labbé SM, Rivard N, Carpentier AC. (2011). 4-Phenylbutyrate reverses endoplasmic reticulum stress and lipotoxicity in human adipose tissue stem cells. 2nd National Obesity Summit, Published in Canadian Journal of Diabetes 35 (2): 139.
• Twisk J, Greentree S, de Wal J, Gagné C, Carpentier AC, Gaudet D, van den Bulk N, Freidig A. (2011). Alipogene tiparvovec gene therapy enhances post-prandial clearance of chylomicrons in lipoprotein lipase deficient patients. 79th European Atherosclerosis Society Congress.
• Shum M, Labbé SM, Carpentier AC, Gallo-Payet N. (2011). Angiotensin Type 2 Receptor (AT2R) activation prevent insulin resistance by modulating adipocyte physiology. Canadian Diabetes Association.
• Bessi VL, Labbé SM, Huynh DN, Carpentier AC, Marleau S, Ong H. (2011). Cardioprotective effects of CD36 ligands following transient ischemia-reperfusion in the mouse. Keystone Symposia ''Lipid Biology and Lipotoxicity''.
• Plourde CÉ, Carpentier AC. (2011). Characterization of Glucose Homeostasis and Caloric Restriction Early after Biliopancreatic Diversion with Duodenal Switch. Canadian Diabetes Association.
• Labbé SM, Ouellet V, Blondin DP, Haman F, Turcotte EE, Richard D, Carpentier AC. (2011). Cold induced thermogenesis in brown adipose tissue in humans. Canadian Diabetes Association.
• Trottier A, Battista MC, Simoneau-Roy J, Carpentier AC, Geller D, Baillargeon JP. (2011). Early metabolic and endocrine perturbations in first degree relative adolescent girls of polycystic ovary syndrome women. 93rd Annual Meeting of the Endocrine Society.
• Trottier A, Battista MC, Simoneau-Roy J, Carpentier AC, Geller D, Baillargeon JP. (2011). Early metabolic and endocrine perturbations in pre- or peripubertal girls with a first degree relative with polycystic ovary syndrome. Androgen Excess & PCOS Society 9th Annual Meeting.
• Trottier A, Battista MC, Carpentier AC, Simoneau-Roy J, Geller D, Baillargeon JP. (2011). Early metabolic and endocrine perturbations in pre-or peripubertal girls with a first degree relative with polycystic ovary syndrome. American Society for Reproductive Medicine 67th Annual Meeting.
• Labbé SM, Noll C, Grenier-Larouche T, Lavallée E, Phoenix S, Guérin B, Turcotte EE, Carpentier AC. (2011). Effect of weight loss on organ-specific dietary fatty acid uptake in impaired glucose tolerance. Canadian Diabetes Association.
• Grenier-Larouche T, Labbé SM, Rivard N, Carpentier AC. (2011). Effet des chaperons chimiques sur le stress du réticulum endoplasmique et la biologie de l'adipocyte. 3e Réunion annuelle de la plateforme COLosSUS.
• Grenier-Larouche T, Labbé SM, Noll C, Carpentier AC. (2011). Effet du 4-Phenylbutyrate dans un modèle nutritionnel de diabète de type 2. 13e Journée scientifique de l'Axe des maladies endocriniennes et métaboliques du Centre de recherche clinique Étienne-Le Bel.
• Labbé SM, Bilodeau L, Gallo-Payet N, Carpentier AC. (2011). Glucose and fatty acid heart and brain uptake in WT and AT2 receptor-deficient mice. 37e Colloque de la Société de Neuroendocrinologie et 4e Colloque franco-québécois.
• Labbé SM, Grenier-Larouche T, Lavallée E, Lessard D, Thibodeau C, Phoenix S, Guerin B, Turcotte EE, Carpentier AC. (2011). Impact des acides gras alimentaires (AGA) dans le développement de la lipotoxicité chez des sujets intolérants au glucose (IG+). 3e Réunion annuelle de la plateforme COLosSUS.
• Twisk J, Frisch F, Greentree S, Petry H, de Wal J, Brisson D, Gagné C, Carpentier AC, Gaudet D. (2011). Improved chylomicron clearance as a marker for long-term efficacy of alipogene tiparvovec (AAV1-LPLS447X gene therapy) in LPLD patients. American Society of Gene & Cell Therapy 14th Annual Meeting.
• Biet M, Ton AT, Benrezzak O, Delabre JF, Morin N, Carpentier AC, Baillargeon JP, Gallo-Payet N, Langlois MF, Dumaine R. (2011). L'augmentation d'acides gras libres circulant augmente l'excitabilité cardiaque chez le chien. 53e Réunion annuelle du CRCQ.
• Bilodeau S, Hivert MF, Xhignesse M, Brown C, Carpentier AC, Langlois MF. (2011). Les étudiants en médecine sont-ils compétents pour soutenir des patients à modifier leurs habitudes de vie ?. 1re journée scientifique du Réseau canadien sur l'Obésité (RCO) Chapitre de l'Université de Sherbrooke.
• Labbe SM, Carpentier AC, Grenier-Larouche T, Guerin B, Lavallee E, Phoenix S, Turcotte E. (2011). Lifestyle changes is associated with a decreased of dietary fatty acid uptake in the heart and improved visceral adipose tissue uptake function in impaired glucose tolerance patients. Keystone Symposia on Lipid Biology and Lipotoxicity (E2).
• Twisk J, Greentree S, Petry H, de Wal J, Brisson D, Gagné C, Carpentier AC, Brunzell JD, Gaudet D. (2011). Lipoprotein Fractionation Studies In LPL Deficient Subjects, Before And After Administration Of Alipogene Tiparvovec (AAV1-LPLS447X Gene Therapy). Arteriosclerosis, Thrombosis and Vascular Biology 2011 Scientific Sessions.
• Hivert MF, Langlois MF, Carpentier AC, Doyon M, Brown C. (2011). Lower Leptin Level Is Associated with Increase in Insulin Resistance over Time in Healthy Young Adults, Independently of Change in Weight. American Diabetes Association's 71st Scientific Sessions.
• Gaudet D, Méthot J, Gagné C, Dery S, Tremblay K, de Wal J, Twisk J, Freidig A, Frisch F, Brisson D, Carpentier AC. (2011). Modifications in Triglyceride-Rich Lipoprotein Metabolism induced by Alipogene Tiparvovec (AAV1-LPLS447X Gene Therapy) correlate with clinical benefit in Patients with Lipoprotein Lipase Deficiency (LPLD). 2nd International Congress on Abdominal Obesity.
• Blondin DP, Labbé SM, Richard D, Turcotte EE, Carpentier AC, Haman F. (2011). Muscle recruitment and muscle-specific substrate uptake in cold-exposed humans evaluated by positron emission tomography coupled to computed tomography (PET/CT). 29th Annual Scientific Meeting of The Obesity Society.
• Ouellet V, Labbé SM, Blondin DP, Haman F, Turcotte E, Richard D, Carpentier AC. (2011). Métabolisme du tissu adipeux brun en réponse à une exposition au froid chez des hommes en santé. 3e Réunion annuelle de la plateforme COLosSUS.
• Grenier-Larouche T, Labbé SM, Rivard N, Carpentier AC. (2011). Palmitate induces endoplasmic reticulum (ER) stress in human adipose tissue stem cells (ADSC) and decreases adipocytes lipid accumulation. Keystone Symposia on Lipid Biology and Lipotoxicity (E2).
• Trottier A, Battista MC, Simoneau-Roy J, Carpentier AC, Geller D, Baillargeon JP. (2011). Perturbations métaboliques et endocriniennes précoces chez des adolescentes à haut risque de développer un syndrome des ovaires polykystiques. 3e Réunion annuelle de la plateforme COLosSUS.
• Trottier A, Battista MC, Moreau B, Simoneau-Roy J, Carpentier AC, Geller D, Baillargeon JP. (2011). Perturbations métaboliques et endocriniennes précoces chez des jeunes filles pré- et péripubertaires à haut risque de développer un syndrome des ovaires polykystiques. 13e Journée scientifique de l'Axe des maladies endocriniennes et métaboliques du Centre de recherche clinique Étienne-Le Bel.
• Kamga C, Carpentier AC, Langlois MF. (2011). Prise en charge du syndrome métabolique par une équipe interdisciplinaire d'obésité: une étude randomisée contrôlée. Matinée des résidents et fellows 2011, 45e Congrès annuel de l'AOGQ.
• Hivert MF, Xhignesse M, Brown C, Carpentier AC, Bilodeau S, Langlois MF. (2011). Profession MD -- Lifestyle : an innovative program to increase medical school students' awareness of their own lifestyle and competency to perform lifestyle counselling. CCME 2011.
• Blondin DP, Labbé SM, Richard D, Turcotte ÉE, Carpentier AC, Haman F. (2011). Recrutement et transport musculaire du 18Fluorodéoxyglucose (18FDG) et de l'acide 18Fluoro-6-thia-heptadécanoïque (8FTHA) lors d'une exposition au froid mesurés par tomodensitométrie couplée à la tomographie par émission de positrons (TEP/CT). 3e Réunion annuelle de la plateforme COLosSUS.
• Labbé SM, Grenier-Larouche T, Lavallée E, Phoenix S, Guérin, Turcotte E, Carpentier AC. (2011). Reduced adipose tissue and increased myocardial uptake of dietary fatty acid is associated with reduced left ventricular ejection fraction in subjects with impaired glucose tolerance. 2nd National Obesity Summit, Published in Canadian Journal of Diabetes 35 (2): 162.
• Grenier-Larouche T, Labbé SM, Noll C, Carpentier AC. (2011). Regulation of insulin sensitivity and fatty acids metabolism by endoplasmic reticulum stress. Canadian Diabetes Association.
• Bessi VL, Labbé SM, Huynh DN, Carpentier AC, Marleau S, Ong H. (2011). Rôle des sécrétines de l'hormone de croissance (GHS) dans la réduction des lésions myocardiques. 3e Réunion annuelle de la plateforme COLosSUS.
• Labbé SM, Ouellet V, Blondin DP, Haman F, Turcotte E, Richard D, Carpentier AC. (2011). Thermogénèse inductible par le froid dans le tissu adipeux brun chez les humains. 13e Journée scientifique de l'Axe des maladies endocriniennes et métaboliques du Centre de recherche clinique Étienne-Le Bel.
• Hivert MF, Brown C, Doyon M, Cuerrier JP, Carpentier AC, Langlois MF. (2010). An educational intervention combining small-group seminars and emails prevents weight gain in young adults over the first two years of university. Obesity 2010, 28th Annual Scientific Meeting.
• Shum M, Ménard S, Emond A, Grenier-Larouche T, Roberge C, Langlois MF, Baillargeon JP, Hallberg A, Carpentier AC, Gallo-Payet N. (2010). Angiotensin II-AT2 receptor stimulation with the selective nonpeptide agonist M24 (C21) prevents diet-induced insulin resistance in rats and modulates several aspects of adipocyte physiology. ENDO 2010.
• Richard D, Ouellet V, Labbé SM, Blondin DP, Turcotte E, Haman F, Carpentier AC. (2010). Brown adipose tissue in human. 11th International Congress on Obesity.
• Naimi F, Baptiste CG, Bellanger S, Raymond I, Gallo-Payet N, Battista MC, Benrezzak O, Carpentier AC, Baillargeon JP. (2010). Caractérisation de l'effet des acides gras libres sur l'hyperandrogénie dans un modèle animal. 6e Journée scientifique du 1er cycle de la Faculté de médecine et des sciences de la santé, Université de Sherbrooke.
• Grenier-Larouche T, Carpentier AC. (2010). Chemical Chaperone Rescue Lipotoxicity in Adipose Tissue Stem Cells. 2010 CDA/CSEM Professional Conference and Annual Meetings.
• Blondin DP, Ouellet V, Carpentier AC, Richard D, Turcotte É, Haman F. (2010). Cold exposure methodology for investigating brown adipose tissue activation in humans. Obesity 2010, 28th Annual Scientific Meeting.
• Ouellet V, Labbé SM, Blondin DP, Haman F, Turcotte É, Richard D, Carpentier AC. (2010). Cold-activated brown adipose tissue metabolism in healthy men. Obesity 2010, 28th Annual Scientific Meeting.
• Vanasse A, Carpentier AC, Courteau J, Drouin C, N. Asghari. (2010). Comparaison des profils thérapeutiques chez les patients diabétiques entre régions rurales et urbaines au Québec. Conférence du Centenaire de l'Association canadienne de santé publique (ACSP).
• Gaudet G, Frisch F, Méthot J, Déry S, Brisson D, Perron P, Essiembre C, Tremblay K, Tremblay G, de Wal J, Twisk J, Tang WW, van Deventer S, Carpentier AC. (2010). Effect of Gene Therapy with Alipogene Tiparvovec on Postprandial chylomicronemia in Patients with Severe HyperTG Due to LPL-Deficiency. Symposium on Postprandial Metabolism, Satellite to the 78th EAS Congress.
• Biet M, Ton AT, Delabre JF, Morin N, Benrezzak O, Carpentier AC, Baillargeon JP, Gallot-Payet N, Langlois MF, Dumaine R. (2010). Fatty rich diet increases cardiac excitability in dog. 21e Colloque des canaux ioniques.
• Twisk J, de Wal J, Petry H, Frisch F, Carpentier AC, Gagné C, Gaudet D. (2010). Gene therapy for LPL deficiency: monitoring clinical efficacy. 28th Annual Congress of the European Society of Gene and Cell Therapy (ESGCT).
• Greentree S, Gaudet G, Brisson D, Méthot J, van den Bulk N, Twisk J, Carpentier AC. (2010). Gene therapy with alipogene tiparvovec (Glybera®) for patients with lipoprotein lipase deficiency results in long term expression and clinical benefit. EASD 40th Annual Meeting.
• Carpentier AC, Frisch F, Labbé SM, Méthot J, Gagné C, Déry S, Tremblay K, de Wal J, Twisk J, Freidig A, Brisson D, Gaudet D. (2010). Gene therapy with alipogene tiparvovec results in enhanced post-prandial clearance of low density chylomicrons in LPLD patients. Resuscitation Science Symposium (ReSS) AHA.
• Langlois F, Hivert MF, Carpentier AC, Brown C, Langlois MF. (2010). Ghrelin levels are associated with hunger but not with restraint, dishinibition or food behavior based on the Three-Factor Eating Questionnaire in healthy young adults. 11th International Congress on Obesity.
• Do DH, Belley-Côté EP, Carpentier AC, Lepage S, Nguyen M, Farand P. (2010). Glycemic response after maximal exercise stress test is not an alternative way to screen glucose intolerance and diabetes mellitus. Canadian Cardiovascular Congress.
• Bellabarba D, Perron P, Carpentier AC. (2010). How long could be the delay between a euthyroid graves ophtalmophathy and the eventual development of overt hyperthyroidism?. 14th International Thyroid Congress.
• Hivert MF, Brown C, Carpentier AC, Langlois MF. (2010). Insulin resistance is associated with increased leptin and C-reactive protein levels but not with reduced adiponectin levels in healthy young adults. 70th Scientific Sessions of the American Diabetes Association.
• Huynh DN, Bessi VL, Labbé SM, Carpentier AC, Ong H, Marleau S. (2010). Le tissue adipeux: cible de l'action du EP80317, un ligand sélectif du CD36 présentant des propriétés cardioprotectrices. 52e Réunion annuelle du CRCQ.
• Kamga C, Carpentier AC, Baillargeon JP, Ardilouze JL, Langlois MF. (2010). Management of the metabolic syndrome in an interdisciplinary obesity clinic: a randomized control trial. Journée de l'Accent sur la recherche APOG.
• Gaudet D, Méthot J, Gagné C, Déry S, Tremblay K, de Wal J, Twisk J, Freidig A, Frisch F, Brisson D, Carpentier AC. (2010). Modifications in Triglyceride-Rich Lipoprotein Metabolism induced by Alipogene Tiparvovec (AAV1-LPLS447X Gene Therapy) correlate with clinical benefit in Patients with Lipoprotein Lipase Deficiency (LPLD). Resuscitation Science Symposium (ReSS) AHA.
• Bessi VL, Huynh DN, Boulahya R, Proulx C, Labbé SM, Lubell WD, Carpentier AC, Ong H, Marleau S. (2010). Novel azapeptide ligands reduce myocardial infarct size after transient left coronary artery ligation in the mouse. Canadian Cardiovascular Congress.
• Grenier-Larouche T, Carpentier AC. (2010). Palmitate Induce Lipotoxicity of Adipose Tissue Stem Cells. 70th Scientific Sessions of the American Diabetes Association.
• Bellabarba, D., Langlois, M.-F., Carpentier, A. (1995). Consensus and controversy on the treatment of differentiated thyroid carcinoma,CONSENSUS ET CONTROVERSE AU SUJET DU TRAITEMENT DES CANCERS THYROIDIENS DIFFERENCIES. Annales D Endocrinologie.

Autres contributions

Activités professionnelles

• Poste d'invité. Diabetes Action Canada (CIHR SPOR Network on Diabetes). Scientific Co-Lead. Toronto, Ontario, Canada. (2022-).
• Poste d'invité. Réseau de recherche sur la santé cardiométabolique, diabète et obésité (CMDO) du FRQS. Deputy Director. Québec, Québec, Canada. (2021-).
• Poste d'invité. Diabetes Action Canada (CIHR SPOR Network on Diabetes). co-PI, Training & Mentoring. Toronto, Ontario, Canada. (2016-2022).
• Poste d'invité. Réseau de recherche sur la santé cardiométabolique, diabète et obésité (CMDO) du FRQS. Scientific Director. Sherbrooke, Québec, Canada. (2012-2021).
• Poste d'invité. Université de Sherbrooke. Director of the Centre d’excellence de l’Université de Sherbrooke sur le diabète, l’obésité et les complications cardiovasculaires. Sherbrooke, Quebec, Canada. (2012-2020).
• Poste d'invité. Centre de recherche du Centre hospitalier universitaire de Sherbrooke. Director of the Diabetes, Obesity and Cardiovascular Complications Research Group. Sherbrooke, Québec, Canada. (2012-2020).
• Poste d'invité. Université de Sherbrooke. Faculty of Medicine and Health Sciences. Assistant Vice-Dean of Research. Sherbrooke, Quebec, Canada. (2010-2012).
• Poste d'invité. Université de Sherbrooke. Director of the Centre de recherche en endocrinologie, métabolisme et signalisation (CREMS). Sherbrooke, Quebec, Canada. (2006-2012).
• Poste d'invité. Centre de recherche du Centre hospitalier universitaire de Sherbrooke. Assistant Director. Sherbrooke, Québec, Canada. (2003-2007).

Divers

• (2025). Adipose tissue metabolic dysfunction in prediabetes and type 2 diabetes: insights from molecular imaging. The DIABIMAGE Study Group Symposium, European Association for the Study of Diabetes, Vienna.
• (2025). Adipose tissue metabolic function and thermogenesis. 1st Adipose Biology Conference meeting, Montreal.
• Radmannia, N., Gauvin, J., Huynh, D.N., Ménard, L., Daneault, C., Ahsanullah, A., Carpentier, A.C., Lubell, W.D., Ruiz, M., Ong, H., Marleau, S., Gravel, S.-P. (2025). Cyclic azapeptide cluster of differentiation-36 receptor modulator attenuates left ventricular injury and temporarily reduces long-chain fatty acid accumulation after myocardial ischemia-reperfusion in mice. Biorxiv.
• (2025). Fonction des tissus adipeux: quantité vs. qualité. Endocrine Weekly Grand Round, Université de Sherbrooke, Sherbrooke.
• (2025). Metabolic imaging of adipose tissue metabolic function in cardiometabolic diseases. Annual Dutch Diabetes Meeting, Wageningen.
• Dumont, L., Richard, G., Espagnet, R., Frisch, F., Fortin, M., Samson, A., Bouchard, J., Fontaine, R., Croteau, E., Phoenix, S., Dubreuil, S., Guérin, B., Turcotte, É.E., Carpentier, A.C., Blondin, D.P. (2025). Shivering, but not adipose tissue thermogenesis, increases as a function of mean skin temperature in cold-exposed men and women. Biorxiv.
• (2025). The adipose tissue-liver metabolic unit in energy expenditure and storage. European Association for the Study of Diabetes, Vienna.
• (2025). The physiological relevance and therapeutic potential of brown and beige adipose tissues. Merck Obesity Input Meeting, Miami.
• Lachance, A., Daoust, J., Pelletier, M., Caron, A., Carpentier, A.C., Biertho, L., Maranzano, J., Tchernof, A., Dadar, M., Michaud, A. (2024). Changes in hypothalamic subunits volume and their association with metabolic parameters and gastrointestinal appetite-regulating hormones following bariatric surgery. Medrxiv.
• (2024). Faire « brunir » le tissu adipeux de l'homme est-il choix thérapeutique. Les journées Klotz « Adipocyte », Société Française d'Endocrinologie et de la Société Francophone du Diabète, Paris.
• (2024). Le parcours de carrière d'un « ancien jeune » médecin endocrinologue en recherche translationnelle et clinique. Symposium de la médecine interne. Groupe d'intérêt en médecine interne de l'Université Laval (https://www.facebook.com/gimiUL), Québec.
• (2024). The adipose-liver unit in cardiometabolic diseases: lessons from bariatric surgery. 2024 MODR Symposium, McMaster University, Hamilton.
• (2023). Advances in tracer and molecular imaging methods of adipose tissue energy metabolism. ICAN Scientific Advisory Board, Paris.
• (2023). Dysmétabolisme des tissus adipeux et maladies cardiométaboliques. Congrès annuel de la fédération hospitalo-universitaire IMPACT (Innovative Medicine for the Prevention an treAtment of Cardiovascular and meTabolic disease), Toulouse.
• (2023). Endocrine debate : « Does activating brown fat contribute ton important metabolic benefits in humans. Endocrine Society's Annual Meeting, ENDO 2023, Chicago.
• Dumont, L., Caron, A., Richard, G., Croteau, E., Fortin, M., Frisch, F., Phoenix, S., Dubreuil, S., Guérin, B., Turcotte, É.E., Carpentier, A.C., Blondin, D.P. (2023). Inhibition of the beta-1 adrenergic receptor does not potentiate mirabegron-stimulated human brown adipose tissue thermogenesis. Medrxiv.
• (2023). Première édition de la conférence de prestige Domenico Regoli : Insuline: Après 100 ans de découvertes, toujours d'actualité en recherche!. Journée de la recherche Gabriel Plaa 2023 du département de pharmacologie et physiologie de l'Université de Montréal, Montréal.
• (2023). Y-a-t-il un rôle de la graisse brune dans les maladies cardiométaboliques chez l'homme?. Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM, Université Paul Sabatier URM1297, Toulouse.
• (2023). Étendre les frontières de l'investigation du diabète et de l'obésité par l'imagerie moléculaire. Webinaire du Centre de formation médicale du Nouveau-Brunswick, Moncton.
• Ye, R.Z., Montastier, E., Frisch, F., Noll, C., Allard-Chamard, H., Gévry, N., Tchernof, A., Carpentier, A.C. (2022). Adipocyte Hypertrophy Associates With Differential in vivo Postprandial Fatty Acid Metabolism, Adipose Single-Cell Landscape and Transcriptional Dynamics. Ssrn.
• (2022). Adipose tissue dysfunction: a target for the prevention and treatment of type 2 diabetes. Annual Diabetes CME Day, London.
• Grenier-Larouche, T., Kwee, L.C., Deleye, Y., Leon-Mimila, P., Walejko, J.M., McGarrah, R.W., Marceau, S., Trahan, S., Racine, C., Carpentier, A.C., Lusis, A.J., Ilkayeva, O., Vohl, M.-C., Huertas-Vazquez, A., Tchernof, A., Shah, S.H., Newgard, C.B., White, P.J. (2022). Altered branched-chain α-keto acid metabolism is a feature of NAFLD in individuals with severe obesity. Medrxiv.
• (2022). Brown adipose tissue: a translational perspective. Henry Friesen Award Lecture, Canadian Society of Endocrinology and Metabolism Brown adipose tissue symposium, Calgary.
• (2022). Brown adipose tissues, lipids and metabolism. Saltin International Graduate Course in Exercise and Clinical Physiology, Queen's Landing, Niagara-On-The-Lake.
• Dr Serge Lepage, cardiologue Dr Jean-François Belleau-Nantel, omnipraticien. (2022). Débat A-GLP1 vs I-SGLT2. Programme d'apprentissage virtuel NovoNordisk.
• (2022). Fonction métabolique des tissus adipeux dans les maladies cardiométaboliques. Colloque de l'ACFAS « Obésité et santé : cibler le poids ou le mode de vie ». 89e Congrès de l'ACFAS.
• Richard, G., Blondin, D.P., Syed, S.A., Rossi, L., Fontes, M.E., Fortin, M., Phoenix, S., Frisch, F., Dubreuil, S., Guérin, B., Turcotte, É.E., Lepage, M., Surette, M.G., Schertzer, J.D., Steinberg, G.R., Morrison, K.M., Carpentier, A.C. (2022). High-fructose feeding suppresses cold-stimulated brown adipose tissue glucose uptake in young men independently of changes in thermogenesis and the gut microbiome. Biorxiv.
• (2022). Nouveautés en diabète. 22e Congrès annuel de la Société des sciences vasculaires du Québec, Montréal.
• (2022). PET applications in Nutrition and Endocrinology. 2022 NORC Summer Imaging Workshop: Metabolic Imaging in Clinical and Translational Research, Denver.
• (2022). Quelques apprentissages de l'étude de la fonction des tissus adipeux en imagerie moléculaire. Réunions scientifiques, Institut de cadiologie de Montréal, Montréal.
• (2022). Table ronde stratégique des experts québécois en cardiologique. HLS Therapeutics.
• (2022). Targeting adipose tissue metabolic function for the treatment of cardiometabolic disorders. MAESTRIA Consortium Meeting, Maastricht.
• (2022). The shapes of tracers: Applying positron emission tomography to energy metabolism. RACMEM 2022: Recent advances & controversies in the measurement of energy metabolism, Québec.
• (2022). Élucidation des mécanismes anti-diabétiques de la chirurgie bariatrique par l'imagerie moléculaire. Réunion annuelle des départements de chirurgie et d'anesthésie de l'Université de Sherbrooke, Sherbrooke.
• (2021). AVC et diabète: quoi de neuf?. 21e Congrès annuel de la Société des sciences vasculaires du Québec.
• (2021). Brown adipose tissue: its relevance for human physiology and health. McGill University Health Center MeDiC (virtual conference), Montréal.
• Ye, R.Z., Noll, C., Richard, G., Lepage, M., Turcotte, É.E., Carpentier, A.C. (2021). DeepImageTranslator: a free, user-friendly graphical interface for image translation using deep-learning and its applications in 3D CT image analysis. Biorxiv.
• (2021). Diabète et AVC: quoi de neuf?. Société des sciences vasculaires du Québec "Diabète et AVC: nouveautés", Montréal.
• (2021). Disordered adipose tissue metabolism in type 2 diabetes: a therapeutic target?. McGill University Health Center Endocrine Rounds (virtual conference), Montréal.
• (2021). Insulin and adipose tissue fatty acids metabolism. EGIR-EASD Study Group Spring Virtual Meeting: Pancreatic hormones and organ cross talk: new insights 100 years after discovery of insulin, Rome.
• (2021). National Institutes of Health Endocrine Training Program Rounds: Adipose tissue-mediated regulation of fatty acid fluxes in cardiometabolic disorders. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney, Bethesda.
• (2021). Rôle du métabolisme des acides gras des tissus adipeux dans les maladies cardiométaboliques. Grand Round of the Department of Medicine, Université de Sherbrooke, Sherbrooke.
• (2021). The CIHR Canada -- Netherlands Consortium on Type 2 Diabetes Research : the TIMED Consortium. The 2001 Diabetes Canada/CSEM Professional Conference, CIHR Symposium on the 100th Anniversary of the Discovery of Insulin.
• (2021). What you need to know about adipose tissue metabolic dysfunction. Eli Lilly Symposium on adipose tissue dysfunction in obesity.
• (2020). Diabète : de l'insuline aux nouvelles molécules... vers la thérapie génique?. Société des Sciences Vasculaires du Québec 20 ans en 2020, Montréal.
• Faramia, J., Hao, Z., Mumphrey, M.B., Townsend, R.L., Miard, S., Carreau, A.-M., Nadeau, M., Frisch, F., Baraboi, E.-D., Grenier-Larouche, T., Noll, C., Li, M., Biertho, L., Marceau, S., Hould, F.-S., Lebel, S., Morrison, C.D., Münzberg, H., Richard, D., ... Picard, F. (2020). IGFBP-2 Partly Mediates the Early Metabolic Improvements Caused by Bariatric Surgery. Ssrn.
• (2020). Imagerie du métabolisme des gras alimentaires dans le diabète de type 2: vers l'identification d'une nouvelle cible thérapeutique. Journée scientifique Jean-Marie Moutquin, Sherbrooke.
• (2020). Le rôle clé des tissus adipeux dans le diabète et ses complications. Congrès 2020 Association Québécoise des Infirmières et Intervenants en Recherche Clinique, Bromont.
• (2020). Mécanismes de la Rémission Rapide du Diabète de Type 2 Après la Chirurgie Bariatrique: Rôle du Métabolisme des Tissus Adipeux. Congrès virtuel sur les désordres cardiométaboliques et le diabète, Paris.
• (2020). Postprandial Fatty Acid Metabolism in Metabolic Disease. 2020 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium, Universal city.
• (2019). Adipose tissue metabolism: implication for the liver. NAFLD symposium, Seville.
• (2019). Brown fat in cardiometabolic health. 13th Annual Scientific Meeting of the Montreal Diabetes Research Centre, Montréal.
• (2019). Futur du traitement du diabète : au-delà des inhibiteurs de SGL T2. 15es Journées Francophones de l'Insuffisance Cardiaque de la Société Française de Cardiologie, Rennes.
• Blondin, D.P., Severinsen, M.C., Kuipers, E.N., Jensen, V.H., Miard, S., Jespersen, N.Z., Kooijman, S., Boon, M.R., Fortin, M., Phoenix, S., Frisch, F., Guérin, B., Turcotte, É.E., Haman, F., Richard, D., Picard, F., Rensen, P.C.N., Scheele, C., Carpentier, A.C. (2019). Human BAT Thermogenesis is Stimulated by the β 2-Adrenergic Receptor. Ssrn.
• (2019). Imagerie moléculaire du métabolisme des tissus adipeux : occasions et défis pour la prévention et le traitement du diabète de type 2. Axe obésité, diabète de type 2 et métabolisme de l'IUCPQ, Québec.
• (2019). Imaging of White and Brown Adipose Tissue Metabolism in Humans as a Target for the Prevention and Treatment of Type 2 Diabetes. Antaros Research Group.
• (2019). Implication du métabolisme des acides gras dans la rémission du diabète de type 2 après la chirurgie bariatrique. Symposium de chirurgie bariatrique de l'Université de Laval, Québec.
• Michaud, A., Dadar, M., Pelletier, M., Zeighami, Y., Garcia-Garcia, I., Yau, Y., Nadeau, M., Marceau, S., Biertho, L., Tchernof, A., Louis Collins, D., Richard, D., Dagher, A., Bégin, C., Bouvier, M., Biron, S., Cani, P., Carpentier, A., Dubé, F., ... Vohl, M.C. (2019). Neuroanatomical changes in white and grey matter after sleeve gastrectomy. Biorxiv.
• (2019). Using PET to Define Adipose Tissue and Muscle Nutrient Utilization. Obesity Week, Las Vegas.
• (2019). White and brown adipose tissues in dietary fatty acid partitioning in humans. 2nd CPH BAT International Conference, Copenhagen.
• (2018). Adipose tissue metabolic dysfunction in obesity and type 2 diabetes. International Congress on Obesity and Metabolic Syndrome (ICOMES), Seoul.
• (2018). Critical review of the energy sources of brown adipose tissue thermogenesis in humans. American diabetes Association 78th Scientific Sessions Meeting Planning Committee, Orlando.
• (2018). Gestion du métabolisme par les tissus adipeux blancs et bruns dans le diabète de type 2 . Société Francophone du Diabète, Montréal.
• (2018). La graisse brune : curiosité métabolique ou véritable cible thérapeutique?. Conférences hebdomadaires de l'IRCM (Institut de recherches cliniques de Montréal), Montréal.
• (2018). Métabolisme cardiaque des acides gras et son implication dans le développement de la cardiomyopathie diabétique. 29e édition Rencontres de Cardiologie, Paris.
• (2018). Nouveautés sur les fondations physiopathologiques du diabète de type 2. Congrès scientifique annuel de l'Association des médecins endocrinologues du Québec, Montréal.
• (2018). Pharmacological activation of brown adipose tissue metabolism. Merck -- FMSS Scientific Day, Sherbrooke.
• (2018). Revue de l'année 2018 du laboratoire Carpentier. Endocrine Grand Round, division of Endocrinology, Sherbrooke.
• (2018). Syndrome métabolique et ses répercussions cliniques chez la femme. Journées annuelles de ménopause de La Société canadienne de ménopause (SIGMA) et le groupe gynécocolpo, Saint-Sauveur.
• (2017). Adipose tissue remodeling and cardiometabolic risk. FRQS Delegation in China for the development of Quebec-China collaborations in cardiology and cardiometabolic disorders.
• (2017). Dietary fatty acid spillover to the heart : a novel target for the prevention and treatment of diabetic cardiomyopathy ?. 4th Banting & Best Diabetes Centre/Joslin Diabetes Center/University of Copenhagen Conference, Toronto.
• (2017). Dysfonction des tissus adipeux et risque cardiométabolique. Conférences du département de pharmacologie et physiologie de l'Université de Montréal, Montreal.
• (2017). Dérèglement métabolique et cardiovasculaire précoce dans le diabète de type 2 : quel rôle dans les démences neurodégénératives. Synergie franco-québécoise de l'Académie nationale de médecine : rencontres médicales et scientifiques France-Québec, Quebec.
• (2017). Fatty acid metabolism in the human heart. 85th Annual Meeting of the European Atherosclerosis Society (EAS), Prague.
• (2017). TEP-IRM pour évaluer la dysrégulation métabolique : une influence majeure pour la maladie d'Alzheimer. Synergies franco-québécoises de l'Académie nationale de médecine (ANM) : Rencontres médicales et scientifiques France-Québec, Québec.
• (2016). Adipose tissues: metabolic valves for an obesogenic environment. 2e Symposium de la Chaire JA DeSève, Institut de recherches cliniques de Montréal, Montreal.
• (2016). Advances in molecular imaging for personalized nutrition and care for type 2 diabetes. Seminar Series fort he 2015-16, McGill University, Montréal.
• (2016). Brown adipose tissue : is it relevant for caloric balance and pathophysiology in humans ?. Seminar Series for the 2015-16, McGill University Health Center, Montreal.
• (2016). Brown adipose tissue metabolism in humans. Research Seminar Series - Sanford Burnham Prebys Medical Discovery Institute (at Lake Nona).
• (2016). Du stéthoscope au clamp jusqu'à l'anti-matière: un voyage en compagnie de William Osler, Ralph DeFronzo et Paul Dirac. Réunion scientifique annuelle 2016 de la Société Québécoise de Lipidologie, de Nutrition et de Métabolisme (SQLNM), du Réseau de recherche en santé Cardiométabolique, Diabète et Obésité (CMDO) du FRQS et du Congrès Colossus, Prix des Fondateurs, Orford.
• (2016). La recherche sur le diabète au CIUSS de l'Estrie CHUS : à la fine pointe et orientée vers le patient. Salon Santé -- Diabète Brome-Missisquoi.
• (2016). Mechanisms of T2DM relapse after bariatric surgery : it is restriction!. Annual Meeting of the Canadian Association of Bariatric Physicians and Surgeons, Toronto.
• (2016). Molecular Imaging of Fatty Acids to Access Cardiometabolic Interventions. International Academy of Cardiovascular Sciences -- Annual Meeting of the North American Section -- Symposium 1 on Cardiovascular Dysfunction in Chronic Diabetes, Sherbrooke.
• (2016). Organ-specific dietary fatty metabolism : unravelling the complex links between the diet and type 2 diabetes (Medicine Grand Round) and Brown adipose tissue (BAT) : is it relevant for caloric balance and pathophysiology in humans ?. Visiting Professor Event McMaster University/St. Joseph's Healthcare, Hamilton.
• (2016). Towards precision nutritional medicine using molecular imaging. MUHC Endocrine Combined Rounds, Montreal.
• (2015). Adipose tissue metabolism and its contribution to metabolic health. The Physiological Society Summer meeting, Cardiff.
• (2015). Caloric restriction is the main mechanism of remission of T2DM after bariatric surgery. 4th Canadian Obesity Summit, Toronto.
• (2015). Ectopic fat deposition in type 2 diabetes: cardiometabolic imaging studies. 5th ICCR Congress on Chronic Societal Cardiometabolic Diseases, Québec.
• (2015). Gaps and new opportunities in clinical practice: targeting the mechanisms of metabolic dysfunctions?. 5th ICCR Congress on Chronic Societal Cardiometabolic Diseases, Québec.
• (2015). Glucolipotoxicity: a figment of our imagination ?. IDF 2015, 23rd World Diabetes Congress 2015, Vancouver.
• (2015). Imagerie du métabolisme des gras alimentaires: vers une médecine nutritionnelle personnalisée. Programme des conférences scientifiques du vendredi midi, CHU Ste-Justine, Montreal.
• (2015). Imaging of type 2 diabetes. Toronto Knowledge Translation Working Group and the RxMD Leaders for Life planning committee, Toronto.
• (2015). La chirurgie pour le diabète de type 2 : une solution à long terme ?. 23e Réunion scientifique annuelle de la Société québécoise d'hypertension artérielle, Montréal.
• (2015). Métabolisme cardiaque des lipides alimentaires : le chemin vers l'insuffisance cardiaque chez le patient diabétique ?. Séminaires multidisciplinaires de cardiologie de l'Institut universitaire de cardiologie et de pneumologie de Québec.
• (2015). Nouveaux outils moléculaires d'exploration des mécanismes liant la nutrition aux complications cardiométaboliques. Conférences scientifiques du CRCHUM, Montreal.
• (2015). Tracers and molecular imaging to reveal mechanisms of type 2 diabetes-related outcomes in humans. CIHR INMD Advisory Board Meeting, Sherbrooke.
• (2015). Une carrière en recherche translationnelle : être prêt, au bon endroit et au bon moment. 23e Réunion scientifique annuelle Société Québécoise d'Hypertension Artérielle (SQHA), Montréal.
• (2015). Vers une médecine de précision des maladies métaboliques à l'aide de la physiologie intégrative et de l'imagerie moléculaire. Symposium du 35ème anniversaire du CRCHUS, Sherbrooke.
• (2014). Métabolisme postprandial des acides gras alimentaires et métabolisme cardiaque. Échanges Scientifiques, IRCM, Montréal.
• (2013). Abnormal dietary fatty acid partitioning in pre-diabetes: implications for cardiac function in humans. Quebec-UK symposium Clinical and public health solutions to the obesity epidemic, Cambridge.
• (2012). Mécanismes d'accumulation ectopique des graisses dans le diabète de type 2. ICAN Institut de Cardiométabolisme & Nutrition, Paris.